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INTRODUCTION
A high cervical spinal cord injury (SCI) in mammals often impairs respiratory motor
function due to disruption of the bulbospinal pathway, the major pathway responsible for
descending respiratory drive. The bulbospinal pathway transmits excitatory respiratory
impulses from the right and left rostral ventral respiratory groups (rVRGs) in the medulla to
depolarize the phrenic nuclei (PN) in the third through sixth cervical spinal segments
(DeVries and Goshgarian, 1989). The PN then transmits the excitatory impulse to the
diaphragm via the phrenic nerves. The surgical model used in the following studies is a left
hemisection at the second cervical spinal segment (C2Hx). The left C2Hx disrupts the
ipsilateral rVRG axonal connections to the left phrenic nucleus and causes ipsilateral (left)
hemidiaphragm paralysis (Fig. 1). Electromyogram (EMG) recordings of the diaphragm
immediately after injury verify the loss of diaphragm activity (Fig. 2).
A secondary latent pathway, the crossed phrenic pathway (CPP), consists of
collateral axons from the contralateral and ipsilateral rVRGs that decussate rostral to or at
the level of the PN (Fig. 1) (Porter, 1895; Moreno et al., 1992; for review Goshgarian, 2003).
The axonal decussation is caudal to the C2Hx, and is therefore intact following injury. Under
normal conditions the neurons involved in the CPP are in a latent state, meaning that they
are not transmitting a signal from the rVRG to the PN to activate the diaphragm. In most
cases, physiological evidence of the CPP can be demonstrated immediately after injury by
the ability to produce an augmented breath (Fig. 2, arrows). An augmented breath occurs
when descending respiratory drive from both rVRGs increase for a single breath. This
activates the diaphragm bilaterally utilizing the non-injured pathway to the right
hemidiaphragm and the CPP to the left hemidiaphragm (Fig. 1). An augmented breath is
characteristically followed by a short period of apnea (Fig. 2) (Golder et al., 2001a).
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Figure 1: Diagram of the bulbospinal pathway. The descending respiratory drive is
carried by the descending bulbospinal respiratory pathways. Pre-motor neurons in the
rostral ventral respiratory groups (rVRGs) located in the ventral medulla send impulses to
the motoneurons of the phrenic nucleus located in the 3rd-6th cervical spinal segments. The
motoneurons in the phrenic nuclei then stimulate the diaphragm to contract via the phrenic
nerve. The location of the spinal hemisection at the second cervical segment is rostral to
the decussation of the latent crossed phrenic pathway leaving these axons uninjured
following a C2Hx. Arrows indicate the pathway over which respiratory impulses travel upon
activation of the crossed phrenic pathway to restore function to the paralyzed
hemidiaphragm under certain conditions. Figure from Phillis and Goshgarian, 2001.

3

Figure 2: EMG recording of the diaphragm immediately after C2Hx. EMG recording of
left (top panel) hemidiaphragm (ipsilateral to C2Hx) and right (bottom panel) hemidiaphragm
immediately following a C2Hx. Note that the left hemidiaphragm is paralyzed (lack of bursts)
following the C2Hx, while the right hemidiaphragm is actively contracting. An augmented
breath is demonstrated (arrows) followed by a short period of apnea. The augmented breath
confirms the crossed phrenic pathway is intact following the C2Hx and is capable of
contacting the diaphragm. The spikes on the left and right are EKG (electrocardiogram)
waves. Buttry and Goshgarian, 2014.
However, in the rat model following a SCI the ipsilateral phrenic nerve can
spontaneously regain phasic function over time (6 weeks or more) by utilizing the CPP
(Nantwi et al., 1999; Golder et al., 2001a; Fuller et al., 2008). In addition, recovery can occur
in a relatively short time frame with pharmacological activation (Nantwi et al., 1996; Nantwi
et al., 2003a; Kajana and Goshgarian, 2008a) or within minutes to hours with a contralateral
phrenicotomy (Porter, 1895 (dog); Goshgarian, 1979 (rat)).
Pharmacological intervention following SCI to activate the latent CPP to regain
diaphragm

function

holds

great

potential.

Clinical

use

of

theophylline

(1,3-

dimethylxanthine), a methylxanthine, in man has been reported as early as 1922 (Schultze-
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Werninghaus and Meier-Sydow, 1982). Theophylline, acting as a bronchodilator, has been
prescribed to treat symptoms of asthma, bronchitis, and emphysema (Aubier et al., 1981;
Moro et al., 2006; Nantwi et al., 1996; Nantwi et al., 2002). Specifically, theophylline, a nonselective phosphodiesterase inhibitor (Butcher and Sutherland, 1962; Horn and McAfee,
1977), has been shown to enhance respiratory drive by acting as an adenosine receptor
antagonist (Eldridge et al., 1983 and 1985; Nantwi and Goshgarian, 1998) that interferes
with both A1 and A2 adenosine receptors (Nantwi et al., 1996). The return of diaphragm
function can be transient or permanent based on the number and frequency of doses
(Nantwi et al., 1996, 1x IV; Nantwi et al., 2003a, multiple oral).
In rats following a C2Hx, systemic (oral or intravenous) administration of
theophylline stimulated the CPP increasing respiratory output and resulted in recovery of
function for both the phrenic nerve and diaphragm (Nantwi et al., 1996; Nantwi and
Goshgarian, 2002).

However, there is limited documentation of clinical studies that

investigate the use of theophylline in humans following SCI to increase respiratory drive
(Ferguson et al., 1999; Bascom et al., 2005; Tzelepis et al., 2006). Lack of data in humans
is due to the high therapeutic dose of theophylline required following SCI that can cause
intolerable side effects including nausea, vomiting, nervousness, increased or irregular
heartbeat, and insomnia (Aubier et al., 1981; Tzelepis et al., 2006; Barnes, 2013). These
side effects are caused by a high concentration of the drug in the plasma leading to global
phosphodiesterase inhibition and adenosine A1-receptor antagonism resulting in a
hyperactive state of many non-targeted neurons (Barnes, 2013). Further efforts to
investigate the clinical outcome of systemic theophylline administration have been
abandoned due to intolerable side effects and lack of quality data.
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Collectively, the past studies provide key information on the anatomy and function
of the CPP that can be stimulated to re-direct the descending respiratory drive following
SCI. In addition, several drugs capable of stimulating the CPP have been characterized in
vivo with rodent models. Unfortunately, systemic administration of theophylline at a
therapeutic dose causes intolerable side effects in humans. Therefore, an alternative
method to administer theophylline was needed. Being able to target the drug to select
respiratory nuclei holds the potential to greatly reduce the therapeutic dose and to reduce
or eliminate unwanted side effects.
The key to delivering a drug to select populations of respiratory nuclei is wheat germ
agglutinin (WGA). WGA is a lectin that has an affinity to sugars, specifically N-acetyl-dglucosamine and sialic acid, which are components of glycoconjugates found on most
neuronal cell membranes (Borges and Sidman, 1982; Fabian and Coulter, 1985; Robertson,
1990). These substances act as neuronal cell membrane receptors when WGA is injected
into muscle (Borges and Sidman, 1982; Fabian and Coulter, 1985; Robertson, 1990). As a
consequence of binding to these specific receptor sites on the motor nerve terminal
membranes, WGA undergoes receptor-mediated endocytosis (Borges and Sidman, 1982).
Subsequently WGA is retrogradely transported along the axon within vesicles, lysosomes,
cisternae and tubules. Following transport to the cell body, the above membrane
compartments fuse and the transported lectin is incorporated into lysosomes (Schwab et
al., 1979; Ruda and Coulter 1982; Broadwell and Balin, 1985). In the electron microscopic
studies of Schwab et al. (1979), the selective release of WGA from postsynaptic dendrites
followed by the rapid uptake of the lectin into presynaptic nerve terminals was observed.
However, after counting the number of presynaptic terminals labeled the authors concluded
that the retrograde transsynaptic transport capability of WGA was far less than other
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macromolecules such as tetanus toxin (Schwab et al., 1979). The precise mechanism for
the release of WGA from postsynaptic dendrites into the synaptic cleft is still unknown.
Since the 1980s it has been suggested that there is a preferential release from
postsynaptic dendrites of physiological active synaptic connections (Harrison et al., 1984,
1986; Jankowska, 1985). This was initially determined by observing the location and
number of labeled motoneurons and propriospinal neurons in the spinal cord of cats and
rats following the injection of wheat germ agglutinin conjugated to horseradish peroxidase
(WGA-HRP) into motor nerves of chronically anesthetized and awake animals (Harrison et
al., 1984; Jankowska, 1985). Furthermore, the extent of neuronal labeling was enhanced
when the motor nerves were stimulated which facilitated synaptic activity to the
motoneurons (Harrison et al., 1984; Jankowska, 1985). Commonly, as in these studies
mentioned, WGA is conjugated with HRP in order to visualize the locations of WGA
following injection. Phrenic motoneurons (PMNs) are unique in that they maintain a phasic
discharge regardless of whether an animal is anesthetized or awake. Neurons in the rVRG
are responsible for maintaining this discharge (Ellenberger and Feldman, 1988) and this is
the presumed basis for the activity-dependent retrograde transsynaptic labeling of both
PMNs and rVRG pre-motor neurons when WGA-HRP is injected into the diaphragm
following a C2Hx (Moreno et al., 1992; Fig. 3).
Based on the demonstration of transsynaptic transport of WGA-HRP in the phrenic
motor system following SCI (Moreno et al., 1992), WGA-HRP was utilized to target drug
delivery to the motoneurons of the PN and pre-motor rVRG neurons involved in respiration.
In order to bind theophylline (or drug of choice) to WGA-HRP a carrier was needed to
facilitate the chemical conjugation. In vivo application of gold (Au) nanoparticles (NPs) has
been established in the literature and are known their biocompatibility and for easy
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attachment of various structures via chemical bonds to the Au (De Jong et al, 2008; Chen
et al., 2009; Duncan et al., 2010; Jain 2010; Thakor et al., 2011; Dreaden et al., 2011, 2012;
Zhou et al., 2013; Cheng et al., 2013; Mieszawska et al., 2013).

Figure 3: Images from rats that had a left C2Hx followed by a contralateral (right)
phrenicotomy and ipsilateral (left) intradiaphragmatic injection of WGA-HRP. Fig. 8
Photomicrograph of transverse section through the C4 level of the spinal cord in the
hemisected rat expressing the crossed phrenic reflex. Note the phrenic motoneurons in the
left PN that have been retrogradely labeled with WGA-HRP. Also note the absence of any
labeled neurons in the right phrenic nucleus (solid black arrow) Fig.9 High power
magnification of the labeled motoneurons of the left phrenic nucleus shown in Fig. 8 Fig. 10
Photomicrograph of a transverse section through the medulla. In this spinal hemisected rat
expressing the crossed phrenic reflex, note the neurons in both rVRGs (enclosed by
rectangles) that have been transsynaptically labeled with WGA-HRP. P, pinhole on right.
IV, fourth ventricle. XII, rostral pole of hypoglossal motor nucleus. Fig. 11 High power
magnification of the area enclosed by the left rectangle in Fig. 10 showing transsynaptically
labeled neurons of the left rVRG. Fig. 12 High power magnification of the area enclosed by
the right rectangle in Fig. 10 showing transsynaptically labeled neurons of the right rVRG.
Figure and caption from Moreno et al., 1992.
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CHAPTER 1: WGA-ALEXA LABELING IN THE PHRENIC MOTOR SYSTEM
Summary
The purpose of this study was to identify and compare the spinal and medullary
centers involved in the respiratory pathway that activate the diaphragm in acutely injured
and chronically injured C2Hx rats. The identification of spinal and medullary centers was
accomplished by the following approaches: i) ipsilateral intradiaphragmatic injection of
WGA-Alexa in the acutely and chronically C2Hx injured rat model, ii) topical application of
WGA-Alexa to the ipsilateral phrenic nerve in the acute C2Hx injured model and in noninjured rats, iii) unilateral intrapleural injection of WGA-Alexa in non-injured rats.
Both intradiaphragmatic and intrapleural injections resulted in bilateral retrograde
labeling of the phrenic nucleus (PN) and bilateral retrograde transsynaptic labeling of the
rostral ventral respiratory groups (rVRGs). Unexpectedly both intradiaphragmatic and
intrapleural injections also resulted in bilateral nucleus ambiguus (NA) labeling. In addition,
following intrapleural injection WGA-Alexa was detected bilaterally in the intercostal motor
nuclei of the thoracic spinal cord. Interestingly topical application of WGA-Alexa to the
phrenic nerve result in only retrograde transport to the ipsilateral PN suggesting
transsynaptic transport is dependent upon the site of application.
Spinal and medullary labeling following Intradiaphragmatic injection of WGA-Alexa
in the acutely C2Hx injured rats compared to the chronically C2Hx rats were strikingly
different. These differences in WGA-Alexa labeling patterns demonstrate injury-induced
spinal and supraspinal plasticity that may contribute to spontaneous recovery of the
diaphragm following injury.
Introduction
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It has been well established that when WGA-HRP is injected into muscle it is
transported in a retrograde fashion back to the motoneuron cell bodies and also
transsynaptically to other neurons within the synaptic chain (Harrison et al., 1984, 1986;
Porter et al., 1985; Moreno et al., 1992). In addition, it has been shown that the transsynaptic
transport is selectively mediated across physiologically active connections rather than silent
or less active connections (Harrison et al., 1984, 1986; Jankowska, 1985). To test the
retrograde transsynaptic capability of WGA-HRP in the phrenic motor system, Moreno and
colleagues (1992) injected WGA-HRP into the hemidiaphragm ipsilateral to a C2Hx after
recovery of the hemidiaphragm was induced by cutting the contralateral phrenic nerve,
activating the CPP. Moreno and colleagues found WGA-HRP labeling in the ipsilateral
PMNs, and bilaterally in the medullary center that provides the excitatory drive to PMNs
during inspiration, the rVRGs (Fig.3). Therefore, Moreno and colleagues (1992)
demonstrated that retrograde transsynaptic transport of WGA-HRP also occurs in the
phrenic motor system following cervical SCI.
In recent years, investigators have become interested in identifying the intracellular
molecular mechanisms and intracellular pathways which may mediate respiratory plasticity
and recovery of the diaphragm after spinal cord injury (Kajana and Goshgarian, 2008a,
2008b, 2009; MacFarlane and Mitchell, 2008; MacFarlane et al., 2009; Wilkerson and
Mitchell, 2009). In order to study such intracellular molecular mechanisms, it would be
advantageous to identify the physiologically active respiratory neurons in the spinal cord
and brainstem that are most likely responsible for mediating the plasticity. This could be
accomplished by using the retrograde transsynaptic transport capability of WGA-HRP
following injections of the tracer into the hemidiaphragm. The identified neurons could then
be isolated (e.g. by laser microdissection) and subjected to intracellular molecular analysis.
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However, visualizing WGA-HRP requires exposure of the tissue sections to chemicals and
reagents that may reduce the quality of the mRNA captured by laser microdissection
(Gjerdrum et al., 2004; Mouledous et al., 2002; Wang et al., 2006). Several laboratories
have documented this problem (Gjerdrum et al., 2004; Mouledous et al., 2002; Wang et al.,
2006) and in our own laboratory we found this to be the case. Therefore, we set out to
investigate an alternative tracer, WGA-Alexa Fluor®, which may have the same retrograde
transsynaptic capabilities as WGA-HRP, but without the requirement of visualizing the
tracer by histochemical staining. In this case, WGA is conjugated to a fluorochrome (Alexa
488 or Alexa 594) and can be visualized simply with a fluorescent microscope (Model et al.,
2009).
The first aim of the present study was to determine if WGA-Alexa 488 would undergo
retrograde transsynaptic transport in the phrenic motor system (i.e., labeling both PMNs
and the rVRG) similar to WGA-HRP. To partly address the underlying mechanism for
transsynaptic transport, the second aim was to investigate the pattern and extent of labeling
that occurs when WGA-Alexa 488 is applied to the phrenic nerve isolated in the cervical
region as compared to intradiaphragmatic injection. In the former case, the tracer diffuses
into the exposed phrenic axons, while in the latter; WGA-Alexa 488 is actively taken up at
the phrenic myoneural junction by WGA receptor-mediated endocytosis.
In the third aim, intradiaphragmatic injections of WGA-Alexa 488 were used to
compare the anatomical pathways that innervate the diaphragm in acutely injured C2Hx
rats to chronically injured C2Hx rats. Based on the observation that WGA-Alexa 488 is
transsynaptically transported over select physiologically active synapses in the respiratory
motor pathway, any changes in labeling pattern occurring over time after injury would
primarily be due to changes in physiologically active synapses in the chronically injured
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C2Hx rat. In addition, the changes in labeling pattern may reveal compensatory routes over
which spontaneous recovery of the diaphragm is achieved after chronic spinal cord injury
(Nantwi et al., 1999).
Due to the invasive nature of the laparotomy procedure required for
intradiaphragmatic injections, the fourth and final aim was designed to investigate a less
invasive labeling technique, intrapleural injection. In 2009 Mantilla and colleagues
introduced a new method of labeling PMNs by injecting cholera toxin subunit beta (CTB)
conjugated to Alexa 488 bilaterally into the intrapleural space. Unfortunately, Mantilla and
colleagues only presented data pertaining to the spinal cord; presumably because CTBAlexa 488 is not a transsynaptic tracer (Cabot et al., 1994, Lee et al., 2009) therefore one
would not expect CTB-Alexa 488 to be identified in the rVRGs. The possibility of
transsynaptic transport of a neuronal tracer to the rVRGs in the medulla following
intrapleural injection remained unresolved. To verify the effectiveness of intrapleural
injections versus intradiaphragmatic, each rat received injections in the intrapleural space
and intradiaphragmatic injections allowing for the comparison of the two techniques. The
studies detailed in the following 3 sections have already been published (Goshgarian and
Buttry, 2014; Buttry and Goshgarian, 2014, 2015).
The pattern and extent of retrograde transsynaptic transport of WGA-Alexa 488 in the
phrenic motor system is dependent upon the site of application
Due to the damaging histochemical techniques required to visualize HRP, an
alternative to the neuronal tracer WGA-HRP was needed to visualize the phrenic motor
system following SCI. WGA conjugated to a fluorochrome, Alexa 488 was selected based
on the characteristic that it can be visualized immediately after sectioning with a fluorescent
microscope (Model et al., 2009). WGA-Alexa tracers are well established, exceptionally
bright, and are excellent for tracing axonal pathways in the central nervous system (Reeber
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et al., 2011a, 2011b; Yamazaki et al., 2009; Panchuk-Voloshina et al., 1999). In addition,
WGA-Alexa 488 labeled cells have distinct granules that are clearly identifiable at higher
magnifications (Fig. 4). Both anterograde (Reeber et al., 2011 a, 2011b) and retrograde
(Yamazaki et al., 2009) track tracing studies have been conducted with WGA-Alexa 488.
Transneuronal/transsynaptic transport of WGA-Alexa 488, however, has never been
demonstrated in vivo. Thus, the first aim of the present study was to determine if WGAAlexa 488 would undergo retrograde transsynaptic transport in the phrenic motor system
similar to WGA-HRP. In addition to partly address the underlying mechanism for WGA
mediated transsynaptic transport, the second aim of the present study was to investigate
the pattern and extent of labeling that occurs when WGA-Alexa 488 is applied to the cervical
phrenic nerve as compared to intradiaphragmatic injection.
Results
All rats used to produce the following data received a left C2Hx or a sham C2Hx
(see methods for details). Rats that received a C2Hx were included in the study only if they
had complete left hemidiaphragm paralysis as confirmed by EMG analysis (Fig. 5). A
minimum survival period of 2 days was sufficient to obtain strong labeling in both the PN
and rVRG.
In all rats that received left hemidiaphragmatic injections of WGA-Alexa 488,
bilateral labeling of the PN was observed (Fig. 6A). Furthermore, the observed spinal cord
labeling was restricted to the PN only; there were no other labeled motoneurons,
propriospinal neurons or dorsal horn neurons identified at the C3–C6 level of the spinal cord
(Fig. 6A). The lack of WGA-Alexa 488 in the cervical spinal tissue with the exception of the
PN demonstrates the selective uptake of WGA following intramuscular injection.
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Figure 4: WGA-Alexa 488 granulation in labeled neurons. A high magnification of
phrenic nuclei motoneurons displaying the granulation appearance of the WGA-Alexa 488
neuronal tracer. Note the specks or granules visible within the cell bodies, axons and
dendrites of the labeled neurons.

Figure 5: Electromyogram of the diaphragm to confirm C2Hx. Electromyograms taken
from both sides of the diaphragm from a rat that was subjected to left C2 spinal cord
hemisection. Note that the right hemidiaphragm is not significantly affected by the
hemisection and displays EMG bursting every time the rat takes a breath. The left
hemidiaphragm, however, is completely paralyzed and does not display EMG activity. The
spikes on the left and right are EKG (electrocardiogram) waves. Calibration bar: 1 s.
Goshgarian and Buttry, 2014.
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Figure 6: Labeling pattern following injection of 50 µl of 2% WGA-Alexa 488 into the
left hemidiaphragm from a rat that was subjected to left C2Hx. (A) Low power view of
a section through the C3 level of the spinal cord, displaying bilateral phrenic nucleus
labeling. Note that there is no other neuron labeling in the spinal cord gray matter and
suggests that the tracer diffuses across the midline of the diaphragm to label both phrenic
nuclei. This same pattern of labeling was seen in all rats with a left hemidiaphragm injection.
The pinhole (P) marks the right side (contralateral to injection). (B) and (C) Each rat
receiving intradiaphragmatic injections of WGA-Alexa 488 also displayed bilateral labeling
of the rVRG indicating retrograde transsynaptic transport. (B) Low power view of the labeled
left rVRG (circled area). SNV, spinal nucleus of V, STV, spinal tract of V is indicated as
landmarks. (C) Same magnification as in (B) showing the right rVRG (circled area) in the
same rat. Note that there is no other medullary center labeled. Small arrows in both (B) and
(C) point to small labeled non-neuronal cells associated with blood vessels. Calibration bar
in (C), also pertains to (B). (D) Higher power view of the labeled left rVRG shown in (B). (E)
Higher power view of the right rVRG shown in (C). Note granulation in both rVRG centers
indicating positively labeled cells. Calibration bar shown in (E) also pertains to (D).
Goshgarian and Buttry, 2014.
In addition, intradiaphragmatic injection of WGA-Alexa 488 resulted in bilateral
labeling of the rVRGs in the medulla. The left (ipsilateral to injection) rVRG is shown in Fig.
6B and D while the right rVRG (contralateral to injection) in the same rat is shown in Fig.
6C and E. Note also the selectivity of the medullary labeling. The area of the rVRG is the
only location labeled. Moreover, the rVRG was always labeled bilaterally (Fig. 6B and C).
In particular, note the absence of labeling in neither gigantocellular reticulospinal neurons
nor raphe neurons known to project to the phrenic nucleus (Dobbins and Feldman, 1994).
In contrast, when WGA-Alexa 488 was applied to the intact isolated left phrenic
nerve, only ipsilateral phrenic nucleus labeling was observed (Fig. 7A). Isolated ipsilateral
phrenic nucleus labeling was observed in all rats. Contralateral phrenic motoneuron labeling
was never observed, nor was there any other spinal cord neurons labeled at the level of the
phrenic nucleus (C3–C6, Fig. 7A). During the pilot studies various methods were tested to
label the phrenic motor system with WGA-Alexa 488; (i) injected the transected or intact
phrenic nerve with the tracer, (ii) applied WGA-Alexa 488-soaked gelfoam to the exposed
phrenic nerve or (iii) attempted to isolate the phrenic nerve with Parafilm® before applying
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the tracer. All of these attempts yielded spurious labeling of phrenic and non-phrenic
neurons in the cervical spinal cord. It was only when we isolated the phrenic nerve and
contained the tracer in a cup (Fig. 8) that we achieved consistent ipsilateral phrenic nucleus
labeling exclusively.
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Figure 7: Labeling pattern shown following WGA-Alexa 488 application for 1 h to the
left phrenic nerve from a rat that was subjected to left C2Hx. (A) Low power view of the
C4 level of the spinal cord showing phrenic nucleus labeling only on the left side (ipsilateral
to nerve application). The pinhole (P) marks the right side of the spinal cord. Note that no
other neurons are labeled in the spinal cord other than the ipsilateral PN. Also note that the
PN is as intensely labeled as it is following diaphragm injection of the tracer (compare this
figure with Fig. 6A). Left (B) and right (C) sides of the medulla at the level of the rVRG
(circled areas in both (B) and (C)). Note that the rVRGs are not labeled suggesting that
retrograde transsynaptic transport does not occur when the tracer is applied to the phrenic
nerve. SNV, spinal nucleus of V; STV, spinal tract of V is included as landmarks. These
sections are comparable to the sections shown in Fig. 6B and C. Magnification in (B) is the
same as in (C). (D) Higher power view of the rVRG shown in (B) (circled area). (E) Higher
power view of the rVRG shown in (C) (circled area). Note that there is no granulation in the
rVRG neurons indicating that they are not labeled. In order to see these unlabeled centers,
the intensity of the fluorescent scope was increased substantially. Compare background
intensity shown in Fig. 6D and E with these figures. Magnification of (D) is the same as (E).
Goshgarian and Buttry, 2014.

Figure 8: Photographs of the surgical exposure of the left phrenic nerve and the
application of WGA-Alexa 488 to the nerve for 1 h. In all photographs, caudal is at the
top, rostral is at the bottom, lateral is to the left and medial is to the right. (A) Surgical
exposure of the phrenic nerve (PN) as it lays on the ventral surface of the brachial plexus
(BP) before the application of the tracer. V, vagus nerve; C, carotid artery; J, jugular vein.
(B) During the application of the tracer, a cup containing 1.5 _l of 2% WGA-Alexa 488 is
placed so that the nerve is bathed in the solution. Bench top paper (B) is placed in the
surrounding tissue to absorb fluid from the rat during the application period. (C) After the 1
h application period, the cup and the bench top paper is removed and the tissue is gently
swabbed. Note that the phrenic nerve (PN) has a yellow color indicating that the tracer
diffused into the nerve. Scale bar is 3 mm. Goshgarian and Buttry, 2014.
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Interestingly, following the application of WGA-Alexa 488 to the isolated phrenic
nerve, there was no retrograde transsynaptic labeling to the rVRGs or any other medullary
neuronal center observed in any of the rats (Fig. 7B–E). Fig. 7B and C is a section through
the rVRG from a rat in which the phrenic nerve was soaked in WGA-Alexa 488. The
unlabeled left and right rVRG can be seen at low magnification (Fig. 7B and C respectively)
and a higher power view of each is shown (Fig. 7D and E). The medullary level is
comparable to the level showing the labeled rVRGs in (Fig. 6B–E) in which WGA-Alexa 488
was injected into the diaphragm. Initially, because of the activity-dependent nature of
transsynaptic transport using WGA-HRP (Harrison et al., 1984, 1986; Moreno et al., 1992),
we thought there may be a difference in the labeling pattern occurring when WGA-Alexa
488 was applied to the quiescent phrenic nerve (i.e. ipsilateral to a C2 hemisection) versus
an active phrenic nerve (ipsilateral to sham hemisection). However, there was no notable
difference between the C2Hx group and the sham group. Following nerve application, the
only labeled neurons detected were ipsilateral phrenic neurons regardless of whether the
phrenic nerve was quiescent or active.
Discussion
The ability to transsynaptically label PMNs and pre-motor rVRG neurons
responsible for descending respiratory drive (Ellenberger and Feldman, 1988) provides an
anatomical picture to compare various states of the phrenic motor system following spinal
cord injury (Goshgarian et al., 1991). This study shows that retrograde transsynaptic
transport of WGA-Alexa 488 occurs in the phrenic motor system (i.e., bilaterally labeling
PMNs and rVRG pre-motor neurons) when the tracer is injected intradiaphragmatically
similar to WGA-HRP. The bilateral phrenic nucleus labeling was most likely due to WGAAlexa 488 diffusing within the muscle across the midline from the left hemidiaphragm to the
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right and being taken up by the axon terminals in both phrenic nerves since peripheral
crossing of phrenic axons has not been demonstrated in the rat diaphragm (Laskowski and
Sanes, 1987). The right phrenic nerve (RPN) was not cut in the present study as it was in
a previous study investigating WGA-HRP (Moreno et al., 1992). The primary reason the
RPN was not cut was based on the observation that the crossed phrenic phenomenon
(induced by C2Hx and contralateral phrenicotomy) contributes little to the overall ventilation
of the animal (Fuller et al., 2006) and thus, we did not want to subject the experimental
animals to unnecessary respiratory stress.
Bilateral PN labeling following an ipsilateral diaphragm injection is not a unique
finding. Boulenguez et al. (2007) showed that dependent upon the monosynaptic retrograde
fluorescent tracer injected unilaterally in the rat diaphragm, PMNs would be labeled either
bilaterally, ipsilateral, or not at all. Very similar results were observed after horseradish
peroxidase (HRP) injection. Interestingly, injection of the dextran amine, fluororuby and the
carbocyanine, DiAsp, into one hemidiaphragm, always resulted in the exclusive labeling of
ipsilateral PMNs. The authors suggested that the lipophilic properties of DiAsp and the high
molecular weight of fluororuby may prevent their diffusion to adjacent tissues and into the
bloodstream which may have caused the artifactual labeling observed with Fluorogold and
HRP (Boulenguez et al., 2007). The present results show that WGA-Alexa 488 is an
excellent retrograde transsynaptic fluorescent tracer in the phrenic motor system, however
there is consistent diffusion of the tracer in the diaphragm. To prevent bilateral PN labeling,
the addition of a contralateral phrenicotomy to the surgical procedure remains a feasible
option.
Exposure of WGA-Alexa 488 directly to the left phrenic nerve in both C2 hemisected
and sham-hemisected rats was used to assess possible differences between quiescent and
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functionally active PMNs. In spite of the observation that there was WGA-Alexa 488 labeling
isolated to ipsilateral PMNs following application of the tracer to the nerve, there was no
observed transsynaptic labeling to the rVRG in either the C2Hx or sham-hemisected
groups. Based on past studies utilizing alternative tracers in the phrenic motor system (e.g.
HRP, Goshgarian and Rafols, 1981, 1984; CT-HRP, Furicchia and Goshgarian, 1987; and
WGA-HRP, Moreno et al., 1992), a difference in labeling pattern dependent on the site of
tracer administration (i.e. nerve versus diaphragm) has never been reported. The reason
for this difference in labeling pattern may be due to the differences in the mechanisms of
uptake and transport of WGA in the nervous system when the tracer is injected into muscle
versus tracer application to the nerve. Since the phrenic nerve was stripped of its
epineurium and WGA-Alexa 488 was applied directly to the nerve, the tracer may have
entered the nerve primarily by simple diffusion (i.e., not by a receptor-mediated uptake
mechanism). Once within the nerve, the retrograde transport of the tracer back to the cell
body may have occurred as described by Schwab et al. (1979), however, transsynaptic
transport did not occur. Since it has been shown that lectin binding sites are not distributed
uniformly on individual neurons (Hatten et al., 1979), it is possible that WGA-Alexa 488 must
be applied at the phrenic myoneural junction where there may be a high concentration of
WGA receptors in order for transsynaptic transport to occur (Fabian and Coulter, 1985;
Robertson, 1990). The result of the present study is that HRP is not necessary for retrograde
transsynaptic transport in the phrenic motor system; WGA alone, or in this case WGA
conjugated to Alexa, is sufficient to mediate the transport (suggested by Borges and
Sidman, 1982).
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Injection of WGA-Alexa 488 into the ipsilateral hemidiaphragm of acutely and
chronically C2 hemisected rats reveal activity-dependent synaptic plasticity in the
respiratory motor pathways
Based on the data obtained from the acute C2Hx injury model it is suggested that
WGA-Alexa 488 is capable of transsynaptic transport in vivo across select physiologically
active synapses in the phrenic motor system (Goshgarian and Buttry, 2014) similar to that
of WGA-HRP (Moreno et al., 1992). It is likely that the synaptic transfer occurs preferentially
over the connections (i.e. rVRG synapses) that depolarize the PMNs during inspiration
(Ellenberger and Feldman, 1988).
In contrast, Pseudorabies virus Bartha strain (PRV-Bartha), a retrograde
transsynaptic neuronal tracer, demonstrates a diverse pattern of labeling compared to
WGA-Alexa 488 when applied to the phrenic motor system. Following PRV-Bartha
exposure to the diaphragm there is an increase in cell types positive for PRV-Bartha,
compared to cell types positive for WGA-Alexa 488. This is likely due to the ability of PRVBartha to cross all synaptic connections; not just physiologically active synapses (Lane et
al., 2008). Thus, the retrograde transsynaptic transport of PRV-Bartha does not differentiate
plasticity occurring over physiologically active connections versus less active or inactive
connections. Specifically, when PRV-Bartha is applied to the diaphragm after an acute
C2Hx or in non-injured rats, the tracer is detected in ipsilateral PMNs within 48 h,
interneurons bilaterally in laminae VII and X of the cervical cord at 64 h, and cells in the
dorsal horn bilaterally at 72 h (Lane et al., 2008). These results are consistent with those
documented by Dobbins and Feldman (1994) who injected PRV into the phrenic nerve. In
the only major chronic study using PRV as a retrograde tracer in which C2Hx rats survived
up to twelve weeks post C2Hx (Lane et al., 2009), the authors found that the ratio of
interneurons to motoneurons in laminae VII and X both ipsilateral and contralateral to the
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injury site were significantly reduced (though still present) in the chronically C2Hx rats. No
other significant changes were detected after both qualitative and quantitative analyses.
Based on the previously observed transsynaptic labeling properties of WGA-Alexa
488 over select physiologically active synapses in the respiratory motor pathway in the
acute C2Hx injury model; any changes in labeling pattern occurring over time after injury
would primarily be due to changes in physiologically active synapses. Furthermore, the
changes in labeling pattern may reveal compensatory routes over which spontaneous
recovery of the diaphragm is achieved after chronic spinal cord injury (Nantwi et al., 1999).
To determine if there are changes in physiologically active synapses in the chronically
injured system, WGA-Alexa 488 labeling patterns were compared between acutely and
chronically injured C2 hemisected rats.
Results
Immediately following the C2Hx surgical procedure, an EMG of the diaphragm
assessed the extent of hemidiaphragmatic paralysis (Fig. 2). Characteristic of C2Hx rats,
an “augmented breath” (Fig. 2, arrows, Golder et al., 2001b) confirmed the presence of an
intact crossed phrenic pathway (Moreno et al., 1992), over which spontaneous recovery of
the C2Hx paralyzed hemidiaphragm is thought to occur (Nantwi et al., 1999). The sham
C2Hx rats received a C2Hx procedure omitting the actual cut to the cervical spinal cord.
The sham C2Hx rats showed no sign of diaphragm paralysis (Fig. 9).
A second EMG was assessed in the chronic C2Hx and sham rats at immediately
prior to intradiaphragmatic injections of WGA-Alexa 488 to assess the extent of
spontaneous recovery (Fig. 10). Sixty-two percent of the chronically C2Hx rats showed
spontaneous diaphragm recovery based on the return of muscle contractions of the
ipsilateral hemidiaphragm (Fig. 10, top trace). The chronic sham rats displayed right and
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left hemidiaphragm activity similar to the initial EMG following the sham C2Hx procedure
(Fig. 11).

Figure 9: EMG traces from the left and right hemidiaphragm immediately after a
Sham C2Hx. Note that the left hemidiaphragm (top trace) is still intact and functional and
the bursting pattern matches the bursts of the right hemidiaphragm (bottom trace). The
sharp spikes in all traces are EKG activity.

Figure 10: EMG traces from the left and right hemidiaphragm 22 weeks post C2Hx.
This recording was taken from the same rat used in figure 2. There is a moderate return of
the bursting pattern in the left hemidiaphragm (top trace) indicative of spontaneous
recovery. The bursts in the left hemidiaphragm match those in the right hemidiaphragm
(bottom trace). Buttry and Goshgarian, 2014.
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Figure 11: EMG traces from the left and right hemidiaphragm 8 weeks after a Sham
C2Hx. Note that the left hemidiaphragm (top trace) is still intact and functional and the
bursting pattern matches the bursts of the right hemidiaphragm (bottom trace). The sharp
spikes in all traces are EKG activity. Right electrodes were producing excessive noise
during the recordings resulting in a larger background signal.
Analysis of the spinal and medulla tissue from the acutely C2 hemisected rats was
consistent with past studies (Goshgarian and Buttry, 2014). In the previous study only the
cervical spinal cord at the level of the PN was examined, but in the present study, both
cervical and thoracic spinal cord tissue was examined. The great majority of cells that
contained WGA-Alexa 488 were PMNs at the C3-C6 levels of the spinal cord (Figs. 12A–
C), and the rVRG pre-motor neurons in the medulla (Figs. 12D & E). There were no other
neurons labeled at the C3–C6 levels of the spinal cord or in the medulla of the acute C2Hx
rats. However, WGA-Alexa 488 labeling was found in non-neuronal cells associated with
the blood vessels in the medulla (Figs. 12D&E arrows; Goshgarian and Buttry, 2014), as
well as a small number of neurons along the medial ventral border of the ventral horn caudal
to the PN at C7 (Fig. 13A).
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Figure 12: Spinal cord and medulla sections from an acute C2Hx rat following WGAAlexa 488 injection. A, Spinal cord section at the C4 level showing bilateral WGA-Alexa
488 labeling in the phrenic nucleus (encircled areas). Note the absence of WGA-Alexa 488
in any other nuclei. P, pinhole marks contralateral to hemisection. B, Higher magnification
of ipsilateral phrenic nucleus from A. C, Higher magnification of contralateral phrenic
nucleus from A. D, Ipsilateral rVRG (dashed encircled area) in the medulla. E, Contralateral
rVRG (dashed encircled area) in the medulla. Note the absence of WGA-Alexa 488 in any
other neurons. Both D and E show some non-neuronal cells with WGA-Alexa 488 labeling
associated with the blood vessels (arrows). Buttry and Goshgarian, 2014.

Figure 13: C7 spinal cord sections from an acute and a chronic C2Hx rat. A, Spinal
cord section below the level of the phrenic nuclei at C7 of an acute C2Hx rat showing WGAAlexa 488 labeled neurons (large arrow) along the ipsilateral medal ventral border of the
ventral horn. Note the lack of any additional labeled nuclei. B, Spinal cord section at the C7
level of a chronic C2Hx rat with a WGA-Alexa 488 labeled neuron (large arrow) in the same
area as the neurons shown in A. In addition, there is ipsilateral labeling of the dorsal
spinocerebellar tract (dashed encircled area), and interneurons in laminae VII and VIII
(small arrows). Buttry and Goshgarian, 2014.
After a minimum 7-week recovery period, the chronic sham rats were injected with
WGA-Alexa 488 into the left hemidiaphragm. Analysis of the spinal and medulla tissues
revealed bilateral WGA-Alexa 488 labeling in PMNs, neurons along the medial ventral
border of the ventral horn in the cervical cord caudal to the PN, and the rVRG pre-motor
neurons in the medulla were detected in all 3 chronic sham rats. In addition, there were
bilateral WGA-Alexa 488 labeled interneurons primarily in laminae VII and VIII of the
cervical and thoracic cord and bilateral WGA-Alexa 488 labeled intercostal motoneurons in
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the thoracic cord. No other neurons or tracts were detected in the medulla, cervical or
thoracic spinal cord of the chronic sham rats.
The chronically C2Hx rats received WGA-Alexa 488 intradiaphragmatic injections
after a minimum 7-week recovery period. Five of the chronic C2Hx rats exhibited autophagy
of the hind contralateral paw. Due to animal care policy, the severity of the autophagy
determined the endpoint for these rats. Upon analysis of the spinal and medulla tissues
there were no qualitative differences in the WGA-Alexa 488 labeling pattern regardless of
the endpoint. Therefore, all rats were grouped together in a single chronic group.
All chronic C2Hx rats exhibited bilateral WGA-Alexa 488 labeling of PMNs at the
levels of C3–C6 (Figs. 14A & C). In addition, chronic C2Hx rats displayed neurons along
the medial ventral border of the ventral horn caudal to the PN at the C7 level of the spinal
cord (Fig. 13B). WGA-Alexa 488 labeled interneurons were detected bilaterally throughout
the gray matter in all sections examined, primarily in laminae VII and VIII in the C4–T5
region (Figs. 13B, 14, 15B & 16B). Unique to the chronic C2Hx rats was the labeled axons
of the reticulospinal tract (RST) (Fig. 14C), ventral spinocerebellar tract (VSCT) (Fig. 14C),
and dorsal spinocerebellar tract (DSCT) (Figs. 13B, 14C & 15B). All 3 tracts were labeled
strictly ipsilateral to the injury. In all cases the DSCT and VSCT appeared as a fasciculated
group of axons just lateral to the dorsal horn and just lateral to the ventrolateral sulcus,
respectively. The DSCT was identified as far caudal as T5. The RST had a scattered
appearance of axons throughout the lateral funiculus and was present in the upper and mid
cervical regions of the spinal cord. Caudal to the PN in the region of C8/T1, motoneurons
were identified in the motor nuclei for the triceps brachii and were bilaterally labeled with
WGA-Alexa 488 (Fig. 15B). In addition, the motoneurons for the manus (hand) and/or
forearm extensors were bilaterally labeled (Fig. 15B). The rostral/caudal transition from
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forearm to manus could not be clearly identified with absolute certainty. In the thoracic cord
of chronically hemisected rats, predominately at T3–T5, intercostal motoneurons were
bilaterally labeled with WGA-Alexa 488 (Fig. 16B).

Figure 14: C4/C5 spinal cord sections of a chronic C2Hx rat. A, Spinal cord section at
the C4/C5 level showing WGA-Alexa 488 labeling in the phrenic nuclei (solid encircled area)
and labeling in neuronal cells throughout laminae VII and VIII (dashed encircled area and
arrows). B, Higher magnification of dashed encircled area in A showing WGA-Alexa 488
labeling in neuronal cells located in laminae VII and VIII. C, Spinal cord section at the C3
level of a chronic C2Hx rat with bilateral phrenic nuclei (encircled areas) labeling in the
ventral horn. Note also the ipsilateral labeling of the dorsal spinocerebellar tract (dashed
encircled area), ventral spinocerebellar tract (large arrow), and reticulospinal tract (small
arrows) in the lateral funiculus. Note the labeling of neuronal cells throughout laminae VII
and VIII (compare to lack of labeling in Fig. 2A). P, pinhole marks contralateral to
hemisection. Buttry and Goshgarian, 2014.
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Figure 15: C8/T1 spinal cord sections from an acute and a chronic C2Hx rat. A, Spinal
cord section at the C8/T1 level from an acute C2Hx rat showing a complete absence of
WGA-Alexa 488 labeling. B, Spinal cord section at the C8/T1 level from a chronic C2Hx rat
showing ipsilateral labeling of the dorsal spinocerebellar tract (dashed encircled area), as
well as bilateral labeling of triceps brachii motoneurons (large arrows), and forearm/manus
motoneurons (small arrows). Compare to lack of labeling in A. P, pinhole marks
contralateral to hemisection. Buttry and Goshgarian, 2014.

Figure 16: T4/T5 spinal cord sections from an acute and a chronic C2Hx rat. A, Spinal
cord section at the T4/T5 level from an acute C2Hx rat showing a complete absence of
WGA-Alexa 488 labeling. B, Spinal cord section at the T4/T5 level from a chronic C2Hx rat
showing bilateral WGA-Alexa 488 labeled intercostal motoneurons (dashed encircled
areas). Buttry and Goshgarian, 2014.
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The chronic C2Hx rats displayed a very distinct bilateral pattern of medullary labeling
that was consistently detected in all chronic C2Hx rats; a summary of the labeled areas for
the acute C2Hx and chronic C2Hx rats is shown in Fig. 17. In addition to the rVRGs, chronic
C2Hx rats displayed a scattering of raphe neurons that were bilaterally labeled along the
midline (Fig. 18B). Neurons were also labeled in the gigantocellular reticular nuclei (Fig.
18B). The parvicellular reticular nuclei (PRN) were labeled and appeared as a column of
neurons extending tangentially along the dorso-ventral plane (Figs. 18B & 19). The labeled
neurons of the intermediate reticular nuclei were located dorsal to the rVRGs and in a
grouping that at times reached just medial to the most dorsal portion of the labeled neurons
in the PRN (Figs. 18B & 19). The spinal trigeminal nucleus had a scattering of labeled
neurons throughout the nucleus (Fig. 18B). Lastly, neurons were bilaterally labeled
throughout the hypoglossal nuclei (Fig. 20B). Interestingly, the sham rats showed labeling
only in the rVRG. A summary of the anatomical results is presented in Table 1.

Table 1: Location of WGA-Alexa 488 labeling in the medulla and spinal cord of the
acute C2Hx, chronic sham, and chronic C2Hx rats. Buttry and Goshgarian, 2014.
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Figure 17: Drawings of the medulla summarizing all the locations of WGA-Alexa 488
in the acute C2Hx and Chronic C2Hx rats. WGA-Alexa 488 labeled cells and tracts
(darkened areas) in the acute C2Hx rats (A) and in the chronic C2Hx rats (B). A, In the
acute C2Hx rats only the rVRG is labeled bilaterally. B, In the chronic C2Hx rats bilateral
labeling is seen in: rVRG, rostral ventral respiratory group; XII, hypoglossal nucleus; R,
raphe nucleus; Gi, gigantocellular reticular nucleus; I, intermediate reticular nucleus; P,
parvicellular reticular nucleus; V, spinal trigeminal nucleus. IV, fourth ventricle and StV,
spinal tract of V noted as landmarks. Buttry and Goshgarian, 2014.
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Figure 18: Medulla sections from an acute and a chronic C2Hx rat. A, Section from an
acute C2Hx rat showing the medulla with WGA-Alexa 488 labeling in the ipsilateral rVRG.
The contralateral rVRG is not shown at this magnification. B, Section from a chronic C2Hx
rat showing the medulla with WGA-Alexa 488 labeling in the intermediate reticular nucleus
(small white arrow), parvicellular reticular nucleus (large white arrows), rVRG (solid
encircled area), raphe (gray arrows), spinal nucleus of V (small dashed arrows), and
gigantocellular reticular nuclei (dashed encircled area). Buttry and Goshgarian, 2014.

Figure 19: Medulla sections from a chronic C2Hx rat. A, Section from a chronic C2Hx
rat medulla with ipsilateral WGA-Alexa 488 labeling in the intermediate reticular nucleus
(small arrows), parvicellular reticular nucleus (large arrows), and rVRG (encircled area). B,
Section from the same chronic C2Hx rat medulla as A with contralateral WGA-Alexa 488
labeling in the intermediate reticular nuclei (small white arrow), parvicellular reticular nuclei
(large arrow), and part of the rVRG (encircled area). Buttry and Goshgarian, 2014.
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Figure 20: Hypoglossal nuclei from an acute and a chronic C2Hx rat. A, Section from
an acute C2Hx rat showing the medulla with a complete lack of WGA-Alexa 488within the
hypoglossal nuclei. B, Section from a chronic C2Hx rat showing the same level of the
medulla (caudal to the rVRG) with bilateral hypoglossal nuclei WGA-Alexa 488 labeling. IV,
fourth ventricle noted as a landmark. Buttry and Goshgarian, 2014.
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Discussion
The isolated PN and rVRGs labeling of the phrenic motor system following
intradiaphragmatic injection of WGA-Alexa 488 in the acutely injured C2Hx model
demonstrates the selective transsynaptic transport of WGA bound tracers over
physiologically active synapses as previously described in other motor systems (Harrison
et al., 1984, 1986; Jankowska, 1985; Schwab et al., 1979). It has been shown that WGA
selectively binds to N-Acetyl-D-glucosamine and sialic acid on the neuronal cell membrane
and undergoes receptor mediated endocytosis (Fabian and Coulter, 1985; Robertson,
1990; Schwab et al., 1979). In addition, following injection of WGA-HRP, the number and
location of WGA-HRP labeled motoneurons and propriospinal neurons in the spinal cord
were compared between two groups; awake animals and chronically anesthetized animals.
Two studies concluded that motor activity of the injected nerve was necessary for
transsynaptic transport to occur from the motoneurons to the propriospinal neurons
(Harrison et al., 1986 and Jankowska, 1985). Specifically, if the animals were chronically
anesthetized and immobilized, the transsynaptic transport was minimal, whereas
transsynaptic transport increased upon motor nerve stimulation (Harrison et al., 1984;
Harrison et al., 1986; Jankowska, 1985) In contrast, alternative neuronal tracers that are
transported independent of nerve activity have displayed labeling of additional medullary
nuclei and cervical spinal interneurons in C2Hx rat models. For example, injection of
Fluorogold, a monosynaptic tracer, into the phrenic nucleus post-C2Hx or sham C2Hx,
results in bilateral labeling of the rVRGs, Bötzinger complex, gigantocellular reticular
nucleus, nuclei of the tractus solitarius, raphe nuclei, and the vestibular nuclei (Boulenguez
et al., 2007). Although the Fluorogold was injected into the phrenic nucleus and not injected
intradiaphragmatically, Fluorogold still demonstrates the synaptic relationship between the
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neurons at the level of the PN and medullary centers that coordinate respiration, including
diaphragmatic function. Similarly, application of PRV, a transsynaptic neuronal tracer
applied to the diaphragm or phrenic nerve in non-injured or acute C2Hx rats labels the
ipsilateral PMNs, interneurons in laminae VII and X bilaterally, cervical interneurons in the
dorsal horn bilaterally, and the rVRGs (Dobbins and Feldman, 1994; Lane et al., 2008). The
comparison of various tracers resulting in different patterns of neuronal labeling emphasizes
the importance of the WGA component of WGA-Alexa 488 that is responsible for the
selective transport of the tracer across physiologically active synapses (Goshgarian and
Buttry, 2014), similar to that of WGA-HRP (Harrison et al., 1984, 1986; Jankowska, 1985).
The importance of the selectivity of WGA-Alexa 488 is further demonstrated when
comparing the pattern of labeling in the spinal cord and medulla of acutely injured C2Hx
rats versus chronically injured C2Hx rats. The application of WGA-Alexa 488 reveals injury
induced plasticity that alters physiologically active connections within the respiratory motor
pathways.
Initially for the chronic sham model WGA-Alexa 488 was expected to be isolated to
the PN and rVRGs since the hemisection of the cervical spinal cord was omitted. However,
the chronic sham tissue displayed bilateral WGA-Alexa 488 labeled interneurons primarily
in laminae VII and VIII of the cervical and thoracic cord and bilateral WGA-Alexa 488 labeled
intercostal motoneurons in the thoracic spinal cord in addition to phrenic and rVRG labeled
cells This implies that the sham C2Hx surgery including laminectomy of C2, durotomy, and
laparotomy had an impact on the spinal cord environment. This is not surprising since the
traumatic effects of a laminectomy and durotomy (without a hemisection) has been
previously documented and is linked to pseudomeningocele, hypovolemia, activation of
astroglia, herniation of the spinal cord and nerve roots, ischemia, scar tissue, and neuronal
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cell death (Hadley and Goshgarian, 1997; He et al., 1995; Hershman et al., 2013; Hosono
et al., 1995; Macki et al., 2014). In addition, laparotomy has been shown to depress
respiration (Barbalho-Moulim et al., 2011; Sieck and Fournier, 1989). Any of the stated side
effects or a combination of these effects has the potential to disrupt the normal spinal cord
circuitry and provoke spinal plasticity. Interestingly, the sham surgical procedure induces
changes only in the spinal cord. The supraspinal components of the phrenic motor pathway
appear to be unaffected by the sham surgery based on the observation that WGA-Alexa
488 labeling was restricted to the rVRG in the medulla in the sham rats. Therefore, implying
a C2Hx must be carried out to induce supraspinal changes in the respiratory circuitry.
In the chronically injured model, when rats are provided a survival time of at least 7
weeks following a C2Hx, ipsilateral intradiaphragmatic injection of WGA-Alexa 488 followed
by a 48-hour survival time results in the labeling of phrenic, intercostal and forelimb
motoneurons, interneurons in the cervical and thoracic spinal cord, and the ipsilateral RST,
DSCT, and VSCT. Comparison of the WGA-Alexa 488 labeling pattern in each experimental
group suggests that the labeled neurons unique to the chronic C2Hx model (forelimb
motoneurons, RST, DSCT, and VSCT) may participate in newly established or more likely
strengthened synaptic connections to the diaphragm in response to the C2Hx. However,
the anatomical data alone cannot confirm if the WGA-Alexa 488 labeled neurons unique to
the chronic C2Hx rats are responsible for the time-associated functional recovery detected
at the level of the diaphragm in 62% of the chronic C2Hx rats. Regardless, based on the
WGA-Alexa 488 labeled nuclei and tracts in the spinal cord unique to the chronic C2Hx
model, there is an undeniable difference of connectivity in the acute C2Hx model and
chronic sham model compared to the chronic C2Hx model.
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The WGA-Alexa 488 labeled neurons in the spinal cord of the chronically C2Hx rats
are discussed as follows. Several motor nuclei throughout the cervical spinal cord were
bilaterally labeled with WGA-Alexa 488 in addition to the motoneurons within the PN.
Starting at the most rostral aspect and moving in the caudal direction, motor nuclei
containing WGA-Alexa 488 labeled motoneurons that supply the triceps brachii, and the
manus (hand) and/or forearm extensors were identified (Watson et al., 2009). As stated
previously, at this time we cannot confirm the role of each neuronal cell type labeled in the
chronic C2Hx spinal cord system. However, there is a physiological change in the synaptic
connections as demonstrated by the selective transsynaptic transport of WGA-Alexa 488
across physiologically active synapses in the acute C2Hx model and chronic sham model
compared to the chronic C2Hx model. Based on previous work demonstrating reciprocal
interactions between respiration and locomotion generators in the cervicothoracic cord
(Viala and Freton, 1983), one potential role of forelimb motoneurons in the chronically C2Hx
spinal cord could be increased involvement in the coordination of accessory respiratory
muscles to aid in the maintenance of respiration while walking. The coordination of
respiration while walking may become more critical in the chronically C2Hx rat, requiring
additional feedback and corrective measures. This could account for the strengthening of
existing synapses between the respiratory pathway and pathways involved in the
coordination of respiration with motility.
Continuing in the caudal direction, WGA-Alexa 488 labeling was located in the nuclei
containing the intercostal motoneurons in the thoracic spinal cord of the chronic C2Hx rats
and chronic sham rats. It has been established that intercostal motoneurons have existing
connections to the rVRGs to coordinate respiration with movement of the intercostal
muscles (Feldman et al., 1985; Hilaire and Monteau, 1997) in both the non-injured system
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and following cervical spinal cord injury (Bellingham, 1999; Tian and Duffin, 1996). The
appearance of WGA-Alexa 488 labeling in the intercostal motoneurons in the thoracic spinal
cord of the chronic C2Hx rats and chronic sham rats suggests a modification to strengthen
existing synapses in response to the trauma related to the surgical exposures, but not
necessarily the hemisection. Another possibility is, because the hemidiaphragm is atrophied
in the chronic C2Hx rats, the tracer could leak into the intrapleural cavity and directly label
intercostal neurons. However, this would not explain intercostal neuron labeling in the
chronic sham rats demonstrating spontaneous recovery in which the hemidiaphragm is not
atrophied.
In addition to motoneurons, three ipsilateral white matter tracts were identified with
axons containing WGA-Alexa 488 in the chronically C2Hx rats. The RST, DSCT, and VSCT
were identified based on their anatomical location in the ipsilateral funiculi; the tracts were
consistently displayed in all chronic C2Hx rat spinal cords, but not in the chronic sham rats.
The DSCT and VSCT are well established as the pathway to transmit information of
unconscious proprioception of the ipsilateral trunk/thorax and lower/hind limb to the
cerebellum (Bosco and Poppele, 2001; Matsushita and Gao, 1997; Soja et al., 1995;
Stecina et al., 2013; Valle et al., 2000). VSCT neurons located in lamina VII have been
shown to monitor activity of spinal interneuronal networks and descending commands to
the spinal motoneurons and interneurons (Shrestha et al., 2012; Stecina et al., 2013). In
addition, it has been demonstrated that a population of DSCT neurons located in the
thoracic cord in laminae VII and VIII (Tanaka et al., 1990) carries information of chest wall
movements to the cerebellum. Recordings from spinocerebellar tract neurons showed
either rhythmic activity matching that of artificial ventilation or with phrenic nerve activity
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demonstrating a role in feedback and reflex pathways (Hirai et al., 1988; Tanaka and Hirai,
1994).
In our chronically C2Hx model, the axons of the ipsilateral DSCT and ipsilateral
VSCT were consistently labeled with WGA-Alexa 488, suggesting an increase in
communication by the sensory tracts to relay information about the current state of the
thoracic cavity's peripheral wall. Sensory information from the thoracic cavity could play a
feedback role in the coordination of accessory muscles to aid in the compensation of the
lost hemidiaphragm function. Vinit and Kastner (2009) suggested that after a chronic partial
SCI, there is a strategy to by-pass the injury that will consist of redistribution and rewiring
of the descending pathways within the spinal cord through the development of accessory
pathways. Based on the WGA-Alexa 488 labeling present in the chronic C2Hx model, the
DSCT and VSCT could be involved in a strategy to by-pass the injured pathway.
The RST carries the primary descending bulbospinal respiratory pathway; RST
axons had a scattered appearance throughout the lateral and ventromedial funiculi with the
majority of the fibers terminating in the cervical enlargement (Feldman et al., 1985; Lipski
et al., 1994; Nathan, 1963; Nathan et al., 1996; Peterson et al., 1975). Interestingly the RST
was identifiable with WGA-Alexa 488 labeling in the chronically C2Hx model but was not
easily detected in the acutely C2Hx model. A possible explanation to the WGA-Alexa 488
detected in the reticulospinal axons could involve spinal hyper-reflexia that is documented
in chronic (1–12 months) spinal cord injury patients. Spinal hyper-reflexia is caused by new
synapse growth of long-axoned neurons or competitive and activity-dependent synapse
growth (Ditunno et al., 2004). An increase in synaptic activity or an increase in the number
of axons communicating respiratory impulses documented in spinal hyper-reflexia could
account for the WGA-Alexa 488 labeling within the ipsilateral RST axons.
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In the chronic C2Hx rats and chronic sham rats, WGA-Alexa 488 labeled
interneurons were identified throughout the cervical and thoracic spinal cord. The
interneurons were predominately located in laminae VII and VIII. Previous studies have
presented data describing how spinocerebellar tract (DSCT and VSCT) neurons located in
laminae VII and VIII convey information of the central respiratory generator (Matsushita and
Gao, 1997; Qin et al., 2002; Tanaka et al., 1990). In addition, the role of interneurons in the
non-injured or injured spinal cord, specifically within the phrenic motor system involving
communication between the medullary respiratory centers and/or the right and left PN have
been considered (Darlot et al., 2012; Dougherty et al., 2012a, 2012b; Lane et al., 2008;
Lipski et al., 1993; Qin et al., 2002; Saywell et al., 2011). In this study, WGA-Alexa 488
labeled interneurons in the chronic C2Hx and chronic sham spinal cord compared to the
complete lack of interneurons in the acutely C2Hx spinal cord demonstrates injury induced
plasticity that may alter the synaptic function in the chronic C2Hx and chronic sham spinal
cord environment. However, the precise contribution of interneurons remains unclear and
requires further investigation to gather precise details in respect to respiratory function and
the role of interneurons.
WGA-Alexa 488 labeling in the medulla of acutely C2Hx rats compared to the
medulla of chronically C2Hx rats demonstrates injury-induced supraspinal plasticity that
may alter physiologically active synapses within the medulla. Following intradiaphragmatic
injection of WGA-Alexa 488, the acute C2Hx model (and sham) demonstrates isolated
WGA-Alexa 488 labeling of the rVRGs bilaterally. However, in the chronic C2Hx model in
addition to the rVRGs, raphe, hypoglossal, spinal trigeminal, parvicellular reticular,
gigantocellular reticular, and intermediate reticular nuclei, which importantly have all been
demonstrated previously to be associated with respiratory control in acutely hemisected or
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non-injured rats, were consistently labeled bilaterally with WGA-Alexa 488. The labeled
nuclei and possible respiratory-based interactions of these nuclei in the chronic C2Hx model
are as follows.
Raphe neurons were identified along the midline of the medulla. Midline
serotonergic raphe neurons are associated with respiration by influencing respiratory
associated nuclei including the hypoglossal, rVRGs, and PN (Manaker et al., 1992; Barker
et al., 2009; Richerson, 2004 for review). Raphe neurons, rVRG connections to the
trigeminal, and to the gigantocellular nuclei could have a possible role in spontaneous
recovery in the chronically C2Hx model based on the presence of WGA-Alexa 488. All of
the previously listed nuclei have been described as having synaptic connections to one
another (Dobbins and Feldman, 1994; Gaytán and Pásaro, 1998). In addition, it has been
demonstrated that neurons within the gigantocellular nuclei innervate the hypoglossal
(Yang et al., 1995) and have a connection to the C3–C4 region of the spinal cord
(Boulenguez et al., 2007). Golder et al. (2001a) suggested supraspinal plasticity two months
after spinal hemisection based on an altered response in hypoglossal motor output; rVRG
respiratory premotor collaterals have been shown to project to the hypoglossal in addition
to the PN (Lipski et al., 1994).
The parvicellular reticular nuclei (PRN) were labeled in the chronic C2Hx model and
links the function of all of the additional WGA-Alexa 488 labeled nuclei together. The PRN
contains pre-motor neurons with direct projections to the trigeminal that affect motor
behavior of the jaw (orofacial motor control) (Notsu et al., 2008; Nozaki et al., 1993; Sahara
et al., 1996). In addition, the PRN are a source of pre-motor neurons with projections to the
hypoglossal (Shammah-Lagnado et al., 1992), to the intermediate reticular nucleus
(laryngeal function Simonyan et al., 2012), and the gigantocellular among others to control
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jaw and tongue movement during facial movements including those associated with
respiration (Luo et al., 2006; Mogoseanu et al., 1993; Ter Horst et al., 1991; Travers and
Norgren, 1983; Tsumori et al., 2010; Yasui et al., 2004; Zhang and Luo, 2003). Afferents to
the PRN communicate information from sensory structures related to orofacial and
gustatory control, including sensory information regarding respiration (Fay and Norgren,
1997; Minkels et al., 1991; Mogoseanu et al., 1993; Ter Horst et al., 1991; Yasui et al.,
2004). These connections demonstrate the established neuroanatomical framework in a
non-injured system for the participation of the medullary nuclei in respiration that appears
to be in a hyperactive state based on the pattern of WGA-Alexa 488 in the chronically C2Hx
model.
The exact role of each medullary center in respect to spontaneous recovery of
hemidiaphragm function following a C2Hx is far from being completely understood. The use
of WGA-Alexa 488 as a neuronal tracer to detect changes in physiologically active synapses
post injury provides a valuable tool to identify areas of plasticity. The labeled nuclei provided
a starting point to examine the chronic effects of a C2Hx and possible targets for intervention
to regain functional abilities.
WGA-Alexa transsynaptic labeling in the phrenic motor system of adult rats:
Intrapleural injection versus intradiaphragmatic injection
Injection of WGA-Alexa 488 into the diaphragm consistently labels cell populations
involved in the innervation of the diaphragm. Unfortunately, intradiaphragmatic injection
requires a laparotomy, an invasive surgical exposure, shown to adversely affect respiration,
therefore potentially altering functional outcomes (Sieck and Fournier, 1989; BarbalhoMoulim et al., 2011). In 2009 Mantilla and colleagues introduced a new method of labeling
PMNs by injecting cholera toxin subunit beta (CTB) conjugated to Alexa 488 bilaterally into
the intrapleural space. Delivery of a retrograde neuronal tracer by way of intrapleural
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injection to label the phrenic motor system eliminates the need for anesthesia and the
laparotomy required for intradiaphragmatic injections (Mantilla et al. 2009). Following
intrapleural injection the authors reported labeling of PMNs as well as thoracic intercostal
motoneurons and dorsal root ganglion neurons, but there was no evidence of transsynaptic
labeling within the spinal cord tissue examined (Mantilla et al., 2009).
When investigating anatomical changes of the respiratory motor pathway following
spinal cord injury, both the pre-motor neurons in the rVRGs that are responsible for
descending respiratory drive as well as the motoneurons in the PN must be considered.
Mantilla and colleagues (2009) did not report any evidence of transsynaptic transport in the
medulla presumably because CTB-Alexa 488 is not a transsynaptic tracer (Cabot et al.,
1994, Lee et al., 2009). Therefore, the possibility of transsynaptic transport of a neuronal
tracer to the rVRGs in the medulla following intrapleural injection is still a question that has
yet to be resolved.
The first aim of this study was to inject WGA-Alexa 488, a known retrograde
transsynaptic tracer (Goshgarian and Buttry, 2014) into the intrapleural space to determine
if transsynaptic labeling would occur. In carrying out this experiment we found it necessary
to differentiate rVRG neurons from nucleus ambiguus (NA) neurons. The neurons of these
two nuclei are intermingled in the ventrolateral medulla (Feldman and Ellenberger, 1988;
Ellenberger and Feldman, 1990a, 1990b; Hayakawa et al., 2004; Spyer, 2009) and it is
difficult to differentiate a rVRG neuron from a NA neuron by morphology alone. The
identification of WGA-Alexa 488 labeled rVRG neurons would suggest retrograde
transsynaptic labeling from the phrenic nuclei to the rVRG following intrapleural injection.
However, since the NA innervates some targets in the thoracic cavity via the vagus nerve
(lung parenchyma, Hadziefendic and Haxhiu, 1999; bronchus, Fontán et al., 2000; trachea,
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Pérez Fontán and Velloff, 2001), this potential route of tracer uptake following intrapleural
injection must be considered. Exposure of the vagus nerve or vagal nerve targets to WGAAlexa 488 following intrapleural injection resulting in the labeling of NA cells would indicate
retrograde labeling (not transsynaptic labeling). To identify the cell bodies that contribute to
the vagus nerve, True blue, a retrograde tracer incapable of crossing synapses can be
injected directly into the vagus nerve (Payne, 1987). The second aim of this study therefore
was to differentiate labeled neurons identified as rVRG cells and NA cells. Three different
tracers injected into three different locations were used to determine the extent of retrograde
transsynaptic transport following intrapleural injection.
Several combinations of injections were administered to non-injured rats as detailed
in Table 2. The various combinations were chosen to ensure the results were due to the
location of the injections and not the injected substances themselves.

Table 2: The 11 rats included in the intrapleural study and the locations and tracers
injected into each rat. Column 1 lists the Animal Identification. Column 2 lists the weight
at the time of injection for each rat. Columns 3–5 list the tracers injected into each location.
Columns 6 & 7 notes the anatomical plane the medulla and spinal cord tissue samples were
sectioned. Buttry and Goshgarian, 2015.
Results
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Injection of WGA-Alexa 488 (green) into the right intrapleural cavity resulted in
retrograde transport to produce bilateral labeling of PMNs in the cervical spinal cord (C3 –
C6) in 7 of the 9 rats (Fig. 21A, 21E, Table 3). The remaining 2 rats lacked WGA-Alexa 488
labeling following intrapleural injection in all spinal sections examined. Lack of labeling in
the 2 rats was likely due to an injection directly into the lung parenchyma, not the intrapleural
space. At the time of perfusion, the 2 rats that lacked labeling displayed a site of trauma on
the right upper portion of the lung and the lung tissue was notably yellow, the color of WGAAlexa 488 in saline solution. Due to this observation, the 2 rats; TB4 and TB6, were
excluded from quantitative analysis.

Table 3: Cell counts from 270 cervical spinal cord sections sampled from 5 rats.
Column 1 lists the ID for each rat. Rats that received both intradiaphragmatic and
intrapleural injections were included in this cell count. Column 2 lists the number of WGAAlexa 594 labeled cells located in the right phrenic nucleus (PN). Column 3 lists the number
of WGAAlexa 488 labeled cells located in the right PN. Column 4 lists the number of dually
labeled cells with WGAAlexa 594 and WGA-Alexa 488 located in the right PN. Column 5
lists the number of WGA-Alexa 594 labeled cells located in the left PN. Column 6 lists the
number of WGA-Alexa 488 labeled cells located in the left PN. Column 7 lists the number
of dually labeled cells with WGA-Alexa 594 and WGA-Alexa 488 located in the left PN.
Columns 8–10 list the total number of cells (right and left sides combined) labeled with
WGA-Alexa 594, WGAAlexa 488, or with a dual label of WGA-Alexa 594 and 488
respectively. The TB3 spinal cord was sectioned in a sagittal plane, left could not be
differentiated from right therefore only total counts were recorded. TB1 was excluded from
the count due the animal not receiving an intradiaphragmatic injection. TB4 and TB6 were
excluded due to an unsuccessful intrapleural injection. Buttry and Goshgarian, 2015.
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Intradiaphragmatic injection of WGA-Alexa 594 (red, N=8) or WGA-Alexa 488
(green, N=2) into the left hemidiaphragm also resulted in bilateral labeling of PMNs in all
rats examined (Fig. 21A, 21E). At the level of the phrenic nuclei (C3 – C6), both intrapleural
and intradiaphragmatic injection resulted in isolated labeling throughout the phrenic nuclei
in all cervical spinal cord sections examined. There was no labeling in any other neuronal
center at C3 – C6 (Fig. 21, 22). Moreover, there was no evidence of spinal interneurons
labeled with either WGA-Alexa 488 or 594 following intrapleural or intradiaphragmatic
injection. The lack of spinal interneurons confirms the findings in our previous studies
examining WGA-Alexa 488 labeling following intradiaphragmatic injection (Goshgarian and
Buttry, 2014; Buttry and Goshgarian, 2014). Of the WGA-Alexa 488 labeled cells observed
in the PN following a right intrapleural injection, 86 ± 17.9% displayed a dual label with
WGA-Alexa 594 (left intradiaphragmatic injection) (Table 3). This data confirms that
intrapleural injection is an effective method to label PMNs and is comparable to
intradiaphragmatic injection (Mantilla et al., 2009). In addition, following intrapleural injection
WGA-Alexa 488 was detected bilaterally in the thoracic spinal cord in the intercostal motor
nuclei (Fig. 23A) confirming the findings of Mantilla and colleagues (2009). However,
following intradiaphragmatic injection, neither WGA-Alexa 594 (red, N=8) or WGA-Alexa
488 (green, N=2) were detected in the thoracic spinal cord (Fig. 23B) confirming the results
of our previous study (Buttry and Goshgarian, 2014). The labeling of intercostal
motoneurons following intrapleural injection, but not after intradiaphragmatic injection
indicates that the tracer is exposed to phrenic axons exclusively when injected into the
diaphragm (Buttry and Goshgarian, 2014). In contrast, intrapleural injection results in the
tracer being exposed to the entire intrapleural space, in which the tracer is able to diffuse
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freely before coming into contact with multiple muscle targets including the diaphragm and
intercostal muscles.

48

Figure 21: Transverse sections of the cervical spinal cord at the level of the phrenic
nuclei in the same rat following intrapleural and intradiaphragmatic injection. A.
displays a low magnification of the left phrenic nucleus (encircled), B-D display a higher
magnification of A. B displays WGA-Alexa 488 (green filter) labeled cells following a right
(contralateral) intrapleural injection of this tracer. C displays WGA-Alexa 594 (red filter)
labeled cells following a left (ipsilateral) intradiaphragmatic injection. D is a merged image
of B and C; note cells contain either WGA-Alexa 488 (arrow) or 594 alone (θ arrow), or a
mixture of both tracers (noted with *in the nucleus). The dually labeled cells are easily
identified in B and C. E displays a low magnification of the right phrenic nucleus (encircled),
F-H display a higher magnification of E. F displays WGA-Alexa 488 (green) labeled cells
following a right (ipsilateral) intrapleural injection. G displays WGA-Alexa 594 (red) labeled
cells following a left (contralateral) intradiaphragmatic injection. H is a merged image of F
and G; note cells contain either WGA-Alexa 488 (arrows) or a mixture of both tracers (noted
with * in the nucleus). Scale bars are 200μm (A and E) and 50μm (BD and F-H). Buttry and
Goshgarian, 2015.

Figure 22: Sagittal section through the cervical spinal cord following intrapleural and
intradiaphragmatic injection (insert of transverse section for reference). WGA-Alexa 488
(green filter) and WGA-Alexa 594 (red filter) labeling within the right phrenic nucleus
following right intrapleural injection of WGA-Alexa 488 and left intradiaphragmatic injection
of WGA-Alexa 594. Notice cells contain either WGA-Alexa 488 (green, examples noted with
# arrow) or WGA-Alexa 594 (red, examples noted with θ arrow) and cells with a dual label
appear yellowish in color (examples noted with * arrows). Scale bar is 100μm. Buttry and
Goshgarian, 2015.
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The first rat analyzed to validate if intrapleural injection was able to produce spinal
cord and medullary labeling with WGA-Alexa 488 received a right intrapleural injection of
WGA-Alexa 488 followed by an injection of True blue into the right vagus nerve. Forty-eight
hours after injection the rat was sacrificed and the tissue was sectioned. The tissue samples
from the medulla demonstrated labeled cells in the intermingled region of the NA and rVRG.
Some cells were labeled with either WGA-Alexa 488 or True blue (Fig. 24). In addition, there
were numerous cells dually labeled with both WGA-Alexa 488 and True blue demonstrating
that intrapleural injection results in the labeling of NA cells.

Figure 23: T6 spinal cord section following intrapleural and intradiaphragmatic
injection. A, Low power magnification of a transverse section through the spinal cord at the
T6 level showing bilateral WGA-Alexa 488 (green filter) labeling in the region of the
intercostal motor nuclei (encircled areas) following right intrapleural injection of this tracer.
B, image of the same section in A using the red filter to detect WGA-Alexa 594 following left
intradiaphragmatic injection. The WGA-Alexa 594 label (red) is absent (encircled areas).
Thus, intrapleural injection labels intercostal motoneurons, but Intradiaphragmatic injection
does not. Scale bar is 200μm. P; pinhole marks left side. Buttry and Goshgarian, 2015.
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Figure 24: High magnification of the NA and rVRG following intrapleural injection and
vagus nerve injection. This rat received a right intrapleural injection of WGA-Alexa 488
(green) followed by an injection of True blue into the right vagus nerve (blue). The merged
image demonstrates the intermingled relationship between the two labeled cell populations.
Some cells are labeled with either WGA-Alexa 488 or True blue as well as cells dually
labeled with both WGA-Alexa 488 and True blue (noted with * in the nucleus) demonstrating
that intrapleural injection results in the labeling of NA cells.

To further investigate the route of tracer uptake by the NA cells, 8 rats were injected
with 3 types of tracer in 3 different locations (Table 2). Six of the 8 rats that received 3
tracers displayed individually labeled, dual labeled and triple labeled cells in the region of
the rVRG and NA (Fig. 25-27, Table 4). TB4 and TB6 were excluded due to the lack of
WGA-Alexa 488 labeling in the spinal cord as mentioned previously. The following
qualitative and quantitative data includes a total of 82 sections spanning the medulla from
6 rats (summary in Table 4). The left half of the medulla displayed WGA-Alexa 488 and
WGA-Alexa 594 labeling isolated to the rVRG and NA following right intrapleural (WGAAlexa 488) and left intradiaphragmatic (WGA-Alexa 594) injection. Of these cells 18.1 ±
10.8% were observed with only WGA-Alexa 488 (green filter, Fig. 25A), 13.6 ± 7.1% with
only WGA-Alexa 594 (red filter, Fig. 25B), and 68.2 ± 8.9% were dually labeled with both
tracers (yellow in appearance, Fig. 25D). Left intradiaphragmatic injection of WGA-Alexa

51

594 resulted in uptake of the tracer by the phrenic nerve, retrograde transport to the phrenic
nuclei, followed by transsynaptic transport to the rVRGs as demonstrated in our previous
study investigating WGA-Alexa 488 (Goshgarian and Buttry, 2014). Cells containing WGAAlexa 488 following intrapleural injection were labeled by one or more of the following three
potential routes; 1) transsynaptic transport following tracer uptake by the phrenic nerve, 2)
transsynaptic transport following tracer uptake by the intercostal nerves, or 3) retrograde
transport following tracer uptake from the vagus nerve and its extensive branches that
innervate targets in the thoracic cavity. It is important to note that there was a complete
absence of True blue in the left half of the medulla following True blue injection into the right
vagus nerve (Fig. 25C).

Table 4: Cell counts from a total of 82 medulla sections sampled from 6 rats. Column
1 lists the ID for each rat. Rats that received injections in all three locations
(intradiaphragmatic, intrapleural and vagus nerve) were included in this cell count. Columns
2–8 list the numbers of labeled cells located in the right half of the medulla in the region of
the NA and rVRG. Cells were identified as individually labeled (WGA-Alexa 594, WGAAlexa 488, or True blue), dually labeled (any combination of 2 of the 3 tracers), or triple
labeled (all 3 tracers in a single cell). Columns 9–11 list the numbers of labeled cells located
in the left half of the medulla in the region of the NA and rVRG. Cells were identified as
individually labeled (WGA-Alexa 594 or WGA-Alexa 488), or dually labeled with both WGAAlexa 594 and WGA-Alexa 488. TB1 was excluded from the count due the animal not
receiving an intradiaphragmatic injection. TB4 and TB6 were excluded due to an
unsuccessful intrapleural injection. Buttry and Goshgarian, 2015.

52

53

Figure 25: High magnification of the NA and rVRG following intrapleural,
intradiaphragmatic and vagus nerve injection. High power magnification of a transverse
section through the medulla displaying both the left (A-D) and right (E-H) rostral ventral
respiratory groups and the nucleus ambiguus. A and E display WGA-Alexa 488 (green filter)
labeled cells following a right intrapleural injection of this tracer (A and E captured with equal
exposure times). B and F display WGA-Alexa 594 (red filter) labeled cells following a left
intradiaphragmatic injection of this tracer (B and F captured with equal exposure times). C
and G display the absence on the left and presence on the right of True blue (blue filter)
labeled cells following a right vagus nerve injection of this tracer (C and G captured with
equal exposure times). D is a merged image of A-C, notice cells contain either WGA-Alexa
488 (green, θ arrow), WGA-Alexa 594 (red, # arrow), or a dual label and appear yellow in
color (noted with * in the nucleus). All rVRG cells are transsynaptically labeled. The image
shows that not all rVRG cells are dually labeled; some are green only and some are red
only. H is a merged image of E-G. Notice cells contain either True blue alone (nucleus
ambiguus cells, ℧ arrow) or a mixture of two or three of the labels in one cell. The yellow
cells are dually labeled rVRG cells (WGA-Alexa 488 and WGA- Alexa 594, arrow), but the
dually (True blue and WGA-Alexa 594, # arrow) and triple labeled cells (noted with * in the
nucleus) suggests that rVRG and NA cells not only intermingle, but they have a synaptic
relationship. The cells marked with an asterisk in H can be seen with the green, red and
blue filter in E-G respectively. Scale bar is 50μm. Buttry and Goshgarian, 2015.

In comparison, the right half of the medulla displayed WGA-Alexa 488 and WGAAlexa 594 labeling isolated to the rVRG and NA (Fig. 25–27) following intrapleural (WGAAlexa 488) and intradiaphragmatic (WGA-Alexa 594) injection. A total of 189 cells were
identified as rVRG neurons based on the presence of WGA-Alexa 488 alone, WGA-Alexa
594 alone, or a dual label of 488 and 594 and a complete absence of True blue. Of the right
rVRG cells, 9.2 ± 8.6% were observed with WGA-Alexa 488 (green filter, Fig. 25E), 9.3 ±
6.9% with WGA-Alexa 594 (red filter, Fig. 25F), and 81.5 ± 11.8% were dually labeled with
both WGA-Alexa 488 and WGA-Alexa 594 (yellow in appearance, Fig. 25H). However,
unique to the right half of the medulla, True blue (TB) a retrograde tracer incapable of
crossing synapses (Payne, 1987) was injected into the right vagus nerve to identify the
ipsilateral NA cells (Fig. 25G & H). A total of 1026 NA cells contained TB. Of these NA cells,
65.9 ± 15.4% contained TB alone, 3.0 ± 3.5% contained TB with WGA-Alexa 594, 5.1 ±
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5.1%) contained TB with WGA-Alexa 488, and 26.0 ± 9.7% contained all three tracers (Fig.
25H, 26D, 27). In addition to the right NA, TB alone was identified in a scattering of cells
ventral to the NA (Fig. 26C, 26D, & 27), and in the dorsal motor nucleus of vagus (DMX)
(Fig. 28), both isolated to the right side. The anatomical relationship of the rVRG and NA
can be appreciated in both transverse (Fig. 25 & 27) and sagittal (Fig. 26) planes where
both nuclei intermingle within the same cell column in the ventrolateral medulla as described
previously (Feldman and Ellenberger, 1988; Ellenberger and Feldman, 1990a, 1990b;
Hayakawa et al., 2004; Spyer, 2009).
To validate the result of identifying WGA-Alexa 594 in True blue labeled NA cells
following intradiaphragmatic injection, two additional rats, NA1 and NA2 were added. True
blue has a hazy appearance and can produce difficulties when examining tissue at the
cellular level with a fluorescent microscope. In contrast WGA-Alexa fluorochromes have a
distinct granulation resulting in easily identifiable labeled cells. NA1 and NA2 received right
vagus nerve injections of WGA-Alexa 594 followed by left intradiaphragmatic injections of
WGA-Alexa 488. Both rats displayed individually labeled cells of either WGA-Alexa 594 or
WGA-Alexa 488, and dually labeled cells (Fig. 29). This again validates that
intradiaphragmatic injection of WGA-Alexa fluorochromes results in both rVRG and NA
labeled cells.
Following intradiaphragmatic injection of WGA-Alexa 594, the observation of NA
cells containing both TB and WGA-Alexa 594 suggests that WGA-Alexa 594 was
transsynaptically transported from rVRG neurons to NA neurons. It is important to stress
that this is the first anatomical report of a direct synaptic relationship between rVRG and
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Figure 26: Sagittal section of the medulla displaying the right rVRG and the
intermingled cells of the right NA. A displays WGA-Alexa 488 (green filter) labeled cells
following a right (ipsilateral) intrapleural injection of this tracer. B displays WGA-Alexa 594
(red filter) labeled cells following a left (contralateral) intradiaphragmatic injection. C
displays True blue (blue filter) labeled cells following a right (ipsilateral) vagus nerve
injection. D is a merged image of A-C, note that the blue labeled NA cells (arrows) not only
follow the main column of the rVRG, but there is also a scattering of cells ventral to the main
nuclei (arrows in C and D). Note also that many of the cells in the main column are dually
labeled rVRG cells (WGA-Alexa 488 and WGA-Alexa 594, # arrows) or triple labeled NA
cells (* arrows) demonstrating a synaptic relationship with the rVRG and NA cells. The
ventrally extended cells (arrows in C and D) displayed only True blue label. Scale bar is
200μm. Buttry and Goshgarian, 2015.
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Figure 27: NA and rVRG and ventrally extended cells following intrapleural,
intradiaphragmatic and vagus nerve injection. High power magnification of a transverse
section through the medulla displaying the right rostral ventral respiratory group and the
nucleus ambiguus (encircled) labeled after an ipsilateral intrapleural injection of WGA-Alexa
488 (green filter) and a contralateral intradiaphragmatic injection of WGA-Alexa 594 (red
filter). True blue (blue filter) was injected into the ipsilateral vagus nerve to label the NA.
The figure is a merged image of all three tracers; notice cells contain either True blue alone
(NA cells; cells without arrows within the encircled area) or a mixture of two or three of the
labels in one cell (# arrow, True blue and WGA-Alexa 594; θ arrow, True blue and WGAAlexa 488; * arrow, triple label). Notice ventrally extended cells (arrows for examples),
displaying True blue only, extend far ventral to the encircled NA and rVRG nuclei. Scale bar
is 100μm. Buttry and Goshgarian, 2015.
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Figure 28: Dorsal medulla following vagus nerve injection. Low power magnification of
a transverse section through the dorsal medulla displaying the right dorsal motor nuclei of
vagus (DMX) labeled with True blue (blue filter) after ipsilateral injection of True blue into
the vagus nerve. A displays a complete lack of WGA-Alexa 488 (green filter) labeled cells
following a right (ipsilateral) intrapleural injection of this tracer. B displays a complete lack
of WGA-Alexa 594 (red filter) labeled cells following a left (contralateral) intradiaphragmatic
injection. C displays True blue (blue filter) labeled cells within the right DMX (arrow)
following a right (ipsilateral) vagus nerve injection. D is a merged image of A-C. Notice
WGA-Alexa 488 and 594 labeling is completely absent in the DMX. IV notes the 4th ventricle
for reference. Scale bar is 500μm. Buttry and Goshgarian, 2015.
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Figure 29: NA and rVRG following vagus nerve injection and intradiaphragmatic
injection. High magnification of the medulla in the area of the NA and rVRG. This rat
received right vagus nerve injections of WGA-Alexa 594 followed by left intradiaphragmatic
injections of WGA-Alexa 488. Both rats displayed individually labeled cells of either WGAAlexa 594 or WGA-Alexa 488, and dually labeled cells (noted with * in the nucleus). This
again validates that intradiaphragmatic injection of WGA-Alexa fluorochromes results in
both rVRG and NA labeled cells.

select NA cells. Further support of the selectivity of this synaptic relationship is the
observation that all other locations of TB labeled cells, i.e. the DMX (Fig. 28) and the cells
scattered ventral to the main column of the NA and rVRG (Fig. 26C, 26D, and 27) had a
complete lack of WGA-Alexa 594. Similar to intradiaphragmatic injection of WGA-Alexa 594,
following intrapleural injection WGA-Alexa 488 was also absent in the DMX and in the
region ventral to the NA suggesting that WGA-Alexa 488 was transsynaptically transported
from the PN to the rVRG and then to only select cells of the NA.
Discussion
In 2009, Mantilla and colleagues demonstrated retrograde transport of CTB-Alexa
488 to PMNs and intercostal motoneurons after intrapleural injection, but there was no
evidence of transsynaptic transport. This study demonstrated that intrapleural injection of
WGA-Alexa fluorochromes not only labels PMNs and intercostal motoneurons similar to
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CTB-Alexa 488 (Mantilla et al., 2009), but is also transsynaptically transported in a
retrograde fashion to the rVRG and select NA cells in the medulla.
The rVRG and NA have been described as an intermingled column of neurons in
the ventrolateral medulla indistinguishable based on size or morphology (Feldman and
Ellenberger, 1988; Ellenberger and Feldman, 1990; Hayakawa et al., 2004; Spyer, 2009).
In order to distinguish the NA from the rVRG, True blue, a retrograde tracer incapable of
crossing synapses, was injected into the right vagus nerve (Sawchenko and Swanson,
1981a, 1981b; Stuesse and Powell, 1982; Cunningham and Sawchenko, 1989). Following
intrapleural injection, WGA-Alexa 488 was identified in both the rVRG and select NA cells.
Right rVRG neurons were identified based on a dual label of WGA-Alexa 488 (intrapleural
injection) and WGA-Alexa 594 (intradiaphragmatic injection) and a complete absence of TB
(vagus nerve injection). NA cells were identified by TB labeling. Dual labeling of WGA-Alexa
488 (intrapleural injection) and TB was also identified. There are two potential mechanisms
as to how the NA cells became labeled with WGA-Alexa fluorochromes following
intrapleural injection; by retrograde transport via targets of the vagus nerve in the thoracic
cavity or transsynaptic transport via the phrenic motor pathway.
Based on the observed locations of TB labeling, the latter mechanism is more
probable. Following intrapleural injection of WGA-Alexa 488, select cells of the NA were
labeled with WGA-Alexa 488 after transsynaptic transport within the phrenic motor pathway
from the PN to the rVRG and subsequently to the NA. In support, WGA-Alexa 488 labeling
was restricted to specific NA cells intermingled with rVRG cells. WGA-Alexa 488 was never
identified in the other two locations of TB labeling: the DMX and the cells scattered ventral
to the NA.
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Following TB injection into the right vagus nerve, the right DMX and a scattering of
cells ventral to the right NA were labeled with TB in addition to the right NA. The DMX has
been shown to provide preganglionic parasympathetic innervation to the esophagus
(Hadziefendic and Haxhiu, 1999; Hayakawa et al., 2002), larynx (Basterra et al., 1987;
Kobler et al., 1994), trachea (Haxhiu and Loewy, 1996; Atoji et al., 2005), lung parenchyma
(Hadziefendic and Haxhiu, 1999), and myocardium (Stuesse and Powell, 1982). The cells
ventral to the NA are associated with the myocardium (Stuesse and Powell, 1982). These
cells of the DMX and the area ventral to the NA are not related directly to respiration. If the
only route of WGA-Alexa 488 transport to the NA was via uptake by the vagus nerve, the
DMX and cells ventral to the NA would also be expected to exhibit a dual label of TB and
WGA-Alexa 488. However, in all rats WGA-Alexa 488 was isolated to the rVRG and the
intermingling cells of the NA demonstrating a functional significance of the transsynaptic
transport of WGA-Alexa 488 from rVRG to select NA cells. Using physiological techniques,
Ellenberger and Feldman (1990) demonstrated that some of the NA cells intermingled with
the rVRG cells exhibit respiratory related discharge patterns. Previous studies demonstrate
the selective characteristic of WGA-Alexa 488 to be transsynaptically transported over
select physiologically active synapses of the respiratory motor pathway as compared in
acute and chronic spinal cord injured rats (Buttry and Goshgarian, 2014). Following
intradiaphragmatic injection of WGA-Alexa 488 into acutely C2Hx rats, the tracer was
described as being located strictly in the PN and rVRG (Goshgarian and Buttry, 2014; Buttry
and Goshgarian 2014). However, this study demonstrates the transsynaptic transport of
WGA bound conjugates following intradiaphragmatic (as well as intrapleural) injection must
be expanded beyond the rVRG to select cells of the NA in the non-injured rat. The
connections between the NA and the rVRG have been described physiologically before
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(Shannon and Freeman, 1981) and suggest a role in the coordination of respiration with
muscle control over airflow (Ellenberger and Feldman, 1990; Spyer, 2009) mediated by
pharyngeal and laryngeal muscles. Past studies speculated a role of interneurons relaying
information between the NA and rVRG (Ellenberger and Feldman, 1990). However, based
on the lack of interneuron labeling, this study provides anatomical evidence of a direct
synaptic relationship between rVRG and select NA cells which further supports the
contention that transsynaptic transport occurs over physiologically active connections.
Moreover, this study demonstrates that transsynaptic transport of WGA-Alexa
fluorochromes can occur over two synaptic connections linking PMNs with rVRG cells and
subsequently select NA cells.
Closing Statement
The results presented in Chapter 1 demonstrate that WGA-Alexa fluorochromes can
be administered by means of intradiaphragmatic or intrapleural injection to selectively
identify physiologically active connections between motor and pre-motor neurons in the
respiratory circuitry. The importance of the selectivity of WGA-Alexa 488 is undoubtedly
demonstrated when comparing the pattern of labeling in the spinal cord and medulla of
acutely injured C2Hx rats versus chronically injured C2Hx rats. WGA-Alexa 488 reveals
injury induced plasticity that alters physiologically active connections within the respiratory
motor pathways detectable just weeks after injury. As a result, these studies provide
investigators with a new method that eliminates the need of chemical reactions, to examine
plasticity in the respiratory system after spinal cord injury. In addition, the differences
between WGA-Alexa 488 labeling in the acutely vs. chronically injured system provide an
extensive list of nuclei that can be investigated further to determine their role in recovery of
the

diaphragm.

Depending

on

an

investigator’s

needs,

either

intrapleural

or
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intradiaphragmatic injection proves to be an easily executed and dependable method to
label neurons in the respiratory circuitry. Moreover, the application of WGA-Alexa
fluorochromes may provide useful in investigating anatomy prior to and following injury to
other motor systems.
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CHAPTER 2: RECOVERY OF DIAPHRAGM FUNCTION IN THE ACUTELY INJURED
SPINAL CORD MODEL USING A RETROGRADE TRANSSYNAPTIC THEOPHYLLINE
BOUND NANOCONJUGATE
Summary
The primary descending respiratory drive, provided by the bulbospinal pathway,
transmits an excitatory impulse from the rostral Ventral Respiratory Groups (rVRGs) in the
medulla to the phrenic nuclei (PN) in the cervical spinal cord. The PN then stimulates the
diaphragm via the phrenic nerves, resulting in contraction of the diaphragm during
inspiration. Following a spinal cord hemisection at the second cervical segment (C2Hx) the
ipsilateral hemidiaphragm is paralyzed due to the disruption of the rVRG axons descending
to the ipsilateral phrenic nucleus. Systemically administered theophylline activates a
functionally latent crossed phrenic pathway (CPP) which decussates caudal to the
hemisection, activating phrenic motoneurons ipsilateral to the hemisection. The result is
return of function to the paralyzed hemidiaphragm. Unfortunately, in humans systemically
administered theophylline at a therapeutic dose produces many unwanted side effects. In
order to eliminate the side effects of theophylline while still maintaining the ability to
stimulate the CPP, a tripartite nanoconjugate was synthesized in which theophylline was
bound to a neuronal tracer, WGA-HRP, using gold nanoparticles (AuNPs) as the coupler.
Following intradiaphragmatic injection of the nanoconjugate, WGA-HRP selectively targets
the nanoconjugate to phrenic motoneurons initially and then to the premotor neurons in the
rVRG by transsynaptic transport. The ester bond between theophylline and AuNP degrades
following injection, releasing theophylline. This method of targeted drug delivery results in
a return of function to the once paralyzed hemidiaphragm.
Introduction
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According to the National Spinal Cord Injury Statistical Center (NSCISC,
2015) the number of people in the United States affected by SCI who were alive in 2014 is
estimated to be approximately 276,000, (range of 240,000 to 337,000). The life span
expectancy of these individuals after SCI is greatly reduced when the patient is ventilator
dependent (NSCISC, 2015). The reduced life span is due to the fact that respiratory system
complications are a major cause for re-hospitalization and death. The reported leading
causes of death for individuals with a SCI are pneumonia, septicemia, other diseases of the
respiratory system, and cardiovascular diseases (NSCISC, 2015, Yang et al., 2015).
Increasing a patient’s respiratory output with pharmacological intervention could lead to
eliminating ventilator dependence and therefore reduce the chance of infection and
untimely death.
Following a high cervical SCI, specifically a C2Hx, there is damage to the
bulbospinal pathway that transmits an excitatory impulse from the rVRGs in the medulla to
the PN in the cervical spinal cord (C3-C6, rat) (DeVries and Goshgarian, 1989). After injury
the PN is unable to effectively stimulate the diaphragm via the phrenic nerves, resulting
respiratory stress. However, the CPP, remains intact following a C2Hx since the CPP
decussates caudal to the hemisection (Porter, 1895; Moreno et al., 1992; for review
Goshgarian, 2003) (Fig. 1). In the rat model, pharmacological activation of the CPP has
been shown to restore diaphragm function following systemic administration of theophylline
(Nantwi et al., 1996; Nantwi et al., 2003a; Kajana and Goshgarian, 2008a).
Theophylline, acting as a bronchodilator, has an established clinical history as
discussed in the introduction (page 1). However, when administered to humans systemically
(oral or intravenous) at therapeutic doses equal to or greater than 20mg/mL (measured as
plasma levels), there are unwanted side effects such as nausea, vomiting, nervousness,
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increased or irregular heartbeat, restlessness, and insomnia (Tzelepis et al., 2006; Barnes,
2013). The side effects following systemic administration in humans are related to an
elevated plasma concentration of the drug that causes global phosphodiesterase inhibition
and adenosine A1-receptor antagonism, which affects numerous central nervous system
centers (Barnes, 2013). Further efforts to investigate the clinical outcome of systemic
theophylline administration have been abandoned due to intolerable side effects and lack
of quality data.
Collectively, the past studies provide key information on the anatomy and function
of the CPP that can be stimulated to re-establish diaphragm function following SCI. Due to
the intolerable side effects of theophylline at a therapeutic dose in humans, an alternative
to systemic administration was needed. Being able to target the drug to select respiratory
nuclei has potential to greatly reduce the therapeutic dose and to decrease or eliminate
unwanted side effects.
The key to delivering a drug to select populations of respiratory nuclei is wheat germ
agglutinin (WGA). Commonly WGA is bound to horseradish peroxidase (WGA-HRP) as a
means to visualize WGA following chemical reactions. WGA, a lectin, has an affinity to Nacetyl-d-glucosamine and sialic acid which are components of glycoconjugates is found on
most neuronal cell membranes (Borges and Sidman, 1982; Fabian and Coulter, 1985;
Robertson, 1990). These substances act as receptors when WGA-HRP is injected into
muscle (Borges and Sidman, 1982; Fabian and Coulter, 1985; Robertson, 1990).
Subsequently, WGA-HRP undergoes receptor-mediated endocytosis, and is retrogradely
transported within the axon. In the electron microscopic studies of Schwab et al. (1979), the
selective release of WGA-HRP from postsynaptic dendrites followed by the rapid uptake of
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WGA-HRP into presynaptic nerve terminals was observed, thus demonstrating the
retrograde transsynaptic transport of WGA-HRP.
Based on the demonstration of transsynaptic transport of WGA-HRP in the phrenic
motor system following a C2Hx (Moreno et al., 1992), WGA-HRP was utilized to target drug
delivery to the motoneurons of the PN and the pre-motor rVRG neurons involved in
diaphragm function. In order to bind theophylline (or drug of choice) to WGA-HRP, a carrier
was needed to facilitate the chemical conjugation. Gold (Au) nanoparticles (NPs) were
chosen as a carrier. In vivo application of AuNPs has been established in the literature and
are known for their biocompatibility, low toxicity, and easy attachment of various structures
via chemical bonds to the AuNPs (De Jong et al, 2008; Chen et al., 2009; Duncan et al.,
2010; Jain 2010; Thakor et al., 2011; Dreaden et al., 2011; Dreaden et al., 2012; Zhou et
al., 2013; Cheng et al., 2013; Mieszawska et al., 2013).
Following a C2Hx, Minic and colleagues (2016) injected into the ipsilateral
hemidiaphragm a nanoconjugate consisting of WGA-HRP, AuNP and 1,3-dipropyl-8cyclopentylxanthine (DPCPX). DPCPX, a specific A1 adenosine receptor antagonist has
been shown to restore ipsilateral phrenic nerve activity following systemic administration
(Nantwi et al., 1996; Goshgarian and Nantwi, 2001; Kajana and Goshgarian, 2008).
Following injection of the DPCPX nanoconjugate, there was a return of activity to the
ipsilateral phrenic nerve and hemidiaphragm. However, theophylline, not DPCPX, has been
approved for use in humans to treat respiratory diseases. Therefore, the purpose of the
following study was to investigate the possibility that a nanoconjugate could be synthesized
with theophylline in place of DPCPX and used to induced recovery.
The nanoconjugate used in the following study consists of three parts; a transporter
(WGA-HRP), a carrier (gold nanoparticle, AuNP), and a drug (proTHP) (Fig. 30). The
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carrier, AuNP, was used to chemically link the drug to the transporter. To link theophylline
a hydroxymethyl group was added to theophylline creating 7-(hydroxymethyl)-theophylline
or “proTHP” (Zhang et al., 2016). ProTHP was then linked to the AuNP via a biodegradable
ester bond to enable in vivo drug release (Zhang et al., 2016). The experimental
nanoconjugate and all control nanoconjugates were synthesized by our collaborators in the
Department of Chemical Engineering and Materials Science at Wayne State University, Dr.
Guangzhao Mao, Dr. Yanhua Zhang, and Fangchao Liu.

Figure 30: Schematic of the fabrication of the tripartite nanoconjugate.
HCHO/Et3N; formaldehyde/triethylamine; THF, Tetrahydrofuran; HAuCl4, chloroauric acid;
NaBH4, Sodium borohydride; Au, gold; MSA, mercaptosuccinic acid; EDC, 1-Ethyl-3-[3dimethylaminopropyl] carbodiimide hydrochloride; DMAP, 4-Dimethylaminopyridine; WGAHRP, wheat germ agglutinin-horseradish peroxidase; NHS, N-Hydroxysuccinimide. Zhang
et al., 2016.
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Following injection into the diaphragm, similar to WGA-HRP, the nanoconjugate is
expected

to

undergo

receptor

mediated

endocytosis.

Once

endocytosed,

the

nanoconjugate is expected to be transported in a retrograde manner to the PN in the spinal
cord followed by retrograde transsynaptic transport to the rVRGs in the medulla. The ester
bond linking the AuNP to proTHP is transient, resulting in the release of proTHP following
injection (Zhang et al., 2016). In contrast the peptide (amide) bond between WGA-HRP and
the AuNP is permanent.
Visualization of the WGA-HRP-AuNP-proTHP nanoconjugate
A total of 5 rats underwent intradiaphragmatic injections to visualize the location(s)
of the nanoconjugate following injection. An immunohistochemistry technique (see
Methods) was utilized to visualize the WGA component of the nanoconjugate. The WGAHRP-AuNP amide bond is permanent whereas the AuNP-proTHP ester bond is transient.
Therefore, the location of WGA should also identify where the AuNPs are but not
necessarily the proTHP. All 5 rats revealed the same results. WGA positive cells were
identified in the ipsilateral phrenic nuclei in the spinal cord and bilateral in the rVRGs in the
medulla (Fig. 31). These results suggest that the WGA-HRP portion of the nanoconjugate
is capable of being transported to the PN and subsequently to the rVRGs following
intradiaphragmatic injection.
Nanoconjugate synthesis
All nanoconjugates used in this study were synthesized according to Zhang et al.,
2016. To determine the drug concentration of each batch, thermogravimetric analysis (TGA)
was completed on all nanoconjugate batches (Table 5). The variation of proTHP bound to
each AuNP as demonstrated by TGA, highlights the importance of verifying every batch
produced, even if identical protocols were used during synthesis. TGA provides information
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Figure 31: Cervical spinal cord and medulla sections displaying WGA labeling
following nanoconjugate injection. (A) Transverse section of the cervical spinal cord
displaying ipsilateral anti-WGA positive labeling in the phrenic nuclei (PN) following
intradiaphragmatic injection of the WGA-HRP-Au-pro-THP nanoconjugate. There is a lack
of labeling in the contralateral PN. Scale bar 200um, P notes pinhole to mark side
contralateral to the injection. (B) Higher magnification of the ipsilateral PN shown in A
displaying fluorescence from the anti-WGA antibody. (C) Higher magnification of the
contralateral PN shown in A with a complete lack of WGA label. Scale bar 50um. (D and E)
Transverse sections of the medulla at the level of the rVRGs from the same rat shown in A.
(D) Ipsilateral rVRG displaying fluorescence from the anti-WGA antibody. (E) Contralateral
rVRG displaying fluorescence from the WGA antibody. P notes pinhole to mark side
contralateral to the injection. Scale bar 200um. (F) Higher magnification of the ipsilateral
rVRG show in D. (G) Higher magnification of the contralateral rVRG shown in E. Scale bar
50um. Zhang et al., 2016

Synthesis Date

Average Amount of
proTHP molecules
per one AuNP

2/17/2014
3/14/3014
4/4/2014
8/15/2014
1/12/2015
2/17/2015
3/2/2015
6/8/2015
7/20/2015

532.95
277.12
218.030
341.54
768.15
330.076
754.41
202.030
248.212

Concentration of proTHP
(mg/ml) in nanoconjugate
solution containing AuNP =
4mg/ml
1.1508
0.5984
0.471
0.7376
1.6588
0.713
1.6416
0.436
0.536

Table 5: Thermogravimetric analysis of WGA-HRP-AuNP-proTHP nanoconjugates.
Each batch underwent Thermogravimetric analysis (TGA) to determine the drug
concentration of each solution. TGA detects how many proTHP molecules are bound to
each AuNP. The drug concentration in mg/ml can be calculated using the concentration of
the AuNP combined with the TGA data. TGA is necessary to ensure each rat is receiving
the same dose of proTHP when multiple batches are being compared.
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that can be applied to each nanoconjugate batch to calculate the exact volume needed to
deliver a set dose. All nanoconjugate solutions had an AuNP concentration of 4mg/ml. For
example, a nanoconjugate with 202 proTHP molecules per one AuNP results in a proTHP
concentration of 0.436 mg/ml, whereas a nanoconjugate with 248 proTHP molecules per
one AuNP has a proTHP concentration of 0.536 mg/ml. This leads to differences in the
volume required to administer a set proTHP dose. To administer the dose of 0.03mg/kg
proTHP for a 400-gram rat, 28µl of the solution containing 202 proTHP per AuNP must be
administered. In contrast to administer the same dose of 0.03mg/kg proTHP for a 400-gram
rat, 23µl of the solution containing 248 proTHP molecules per AuNP must be administered.
EMG response to WGA-HRP-AuNP-proTHP and control solutions
Five doses of the nanoconjugate based on proTHP concentration (0.03mg/kg,
0.07mg/kg, 0.12mg/kg, 0.14mg/kg, 0.25mg/kg) were analyzed by EMG (Minic et al., 2016)
on days 2 through 14 post injection. All proTHP doses were confirmed with TGA analysis.
EMG functional recovery of the diaphragm after a one-time injection of the nanoconjugate
proTHP dose of 0.03mg/kg, was detected as early as day 2 post nanoconjugate injection
and persisted up to 14 days in 65% of the rats (N=20) (Fig. 32). Similarly, the 0.07mg/kg
proTHP nanoconjugate dose resulted in recovery in 57% of the rats (N=21) (Fig. 33), the
0.12mg/kg proTHP nanoconjugate dose resulted in recovery in 27% of the rats (N=11) (Fig.
34), the 0.14mg/kg proTHP nanoconjugate dose resulted in recovery in 44% of the rats
(N=18) (Fig. 35), and the 0.25mg/kg proTHP nanoconjugate dose resulted in recovery in
14% of the rats (N=7). Nevertheless, there were some noticeable qualitative differences
between the experimental groups. Rats that received a 0.03mg/kg dose often had weaker
bursts compared to those observed in rats in the 0.07mg/kg dose group (Fig. 36). Rats from
the 0.12mg/kg and 0.14mg/kg dose groups typically had stronger bursts similar to the
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0.07mg/kg dose group. However, in several rats from the 0.12mg/kg and 0.14mg/kg dose
groups, the LHD burst frequency was sporadic (non-phasic) and sometimes off rhythm
compared to the right side, a possible effect of over stimulation (Fig. 35). Interestingly
several rats from the 0.14mg/kg group presented challenges while trying to stabilize them
under anesthesia. To reach the anesthetic plane for an EMG procedure, these rats required
multiple supplemental doses of anesthesia compared to one dose needed in all other
groups.

Figure 32: EMG traces day 7 post injection 0.03mg/kg nanoconjugate. Day 7 post
injection of the 0.03mg/kg dose nanoconjugate. There is a return of the phasic bursting
pattern from the left hemidiaphragm (top trace). The bursts from the left hemidiaphragm
match those in the right hemidiaphragm (bottom trace). The sharp spikes in all traces are
EKG activity.
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Figure 33: EMG traces day 2 and day 14 post injection of 0.07mg/kg nanoconjugate.
Both recordings were obtained from the same rat. (A) Day 2 post injection of the 0.07mg/kg
dose nanoconjugate there is a return of the phasic bursting pattern from the left
hemidiaphragm (top trace). The bursts from the left hemidiaphragm match those from the
right hemidiaphragm (bottom trace). (B) Day 14 post injection, the activity has persisted in
the left hemidiaphragm (top trace) and remains phasic and synchronous with the right
hemidiaphragm (bottom trace). In both traces an augmented breath is demonstrated
(arrows) followed by a short period of apnea. This demonstrates that the CPP is intact and
is functional. The sharp spikes in all traces are EKG activity.
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Figure 34: EMG traces day 5 post injection 0.12mg/kg nanoconjugate. Day 5 post
injection of the 0.12mg/kg dose nanoconjugate there is a return of the phasic bursting
pattern from the left hemidiaphragm (top trace). The bursts from the left hemidiaphragm
match those from the right hemidiaphragm (bottom trace). In both traces an augmented
breath is demonstrated (arrows) followed by a short period of apnea. The sharp spikes in
all traces are EKG activity.

Figure 35: EMG traces day 2 post injection 0.14mg/kg dose. (A) and (B), day 2 post
injection of the high dose (0.14mg/kg) nanoconjugate there is a small return of the bursting
pattern (arrows) from the left hemidiaphragm (A and B top traces) but the pattern is sporadic
(non-phasic) and out of sync with the right hemidiaphragm (A and B bottom traces). B,
exhibits an augmented breath followed by a short period of apnea. The sharp spikes in all
traces are EKG activity
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Figure 36: EMG traces from LHD day 7 post injection; 0.03mg/kg vs 0.07mg/kg. Traces
from the left hemidiaphragm of a rat that received a 0.07mg/kg dose (top trace) and a rat
that received a 0.03mg/kg dose (bottom trace). Note in the four areas highlighted that the
burst from the 0.07mg/kg dose produces a more robust burst than the 0.03mg/kg dose.

Injection of a control solution containing a conjugate of AuNP-proTHP 0.03mg/kg
(no WGA-HRP) (N=9), or WGA-HRP-AuNP (no proTHP) (N=8) failed to produced recovery
of the LHD (Fig. 37). To determine the effectiveness of the nanoconjugate, proTHP (7(hydroxymethyl)-theophylline, see methods) in saline (0.07mg/kg) was injected into the
diaphragm. The proTHP dose of 0.07mg/kg resulted in recovery in 40% of the rats (N= 5)
(Fig. 38). Two additional rats were injected with the same saline used to dissolve the
proTHP. Both rats injected with saline lacked functional recovery in all follow up EMG
recordings (Fig. 39).
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Figure 37: EMG traces post injection of control solutions. (A) Following injection of the
WGA-HRP-AuNP control the left hemidiaphragm remains inactive (top trace) with the
exception of the CPP demonstrated by the augmented breath (arrows). The right
hemidiaphragm maintains phasic bursting activity (bottom trace). (B) Following injection of
the 0.03mg/kg AuNP-proTHP control the left hemidiaphragm remains inactive (top trace)
while the right hemidiaphragm maintains phasic bursting activity (bottom trace).

Figure 38: EMG traces day 5 post injection of proTHP 0.07mg/kg in diaphragm.
Following injection of proTHP there is a return of the bursting pattern from the left
hemidiaphragm (top trace) that matches the phasic bursts of the right hemidiaphragm
(bottom trace).
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Figure 39: EMG traces from the left and right hemidiaphragm day 7 post injection of
saline. Day 7 post injection of the saline control the left hemidiaphragm remains inactive
(top trace). The right hemidiaphragm maintains phasic bursting activity (bottom trace).
Statistical significance of functional recovery occurrence, detected with EMG
analysis, was determined using the Chi Square-Fisher’s exact test followed by the
Bonferroni adjustment (Fig 40, Minic et al., 2016). Treatment with 0.03mg/kg of the pro THP
nanoconjugate resulted in significantly greater proportion of rats achieving functional
recovery when compared to the 0.25mg/kg dose (p=0.033). In addition, treatment with
0.03mg/kg, 0.07mg/kg, or 0.14mg/kg of the proTHP nanoconjugate resulted in a
significantly greater proportion of rats achieving functional recovery when compared to the
control 0.03mg/kg AuNP-proTHP; (p=0.002), (p=0.009), (p=0.031) respectively. Treatment
with 0.03mg/kg, 0.07mg/kg, or 0.14mg/kg also resulted in a significantly greater proportion
of rats achieving functional recovery when compared to the control WGA-HRP-AuNP;
(p=0.001), (p=0.004), (p=0.026) respectively.

78

Figure 40: Percent Recovery Detected by EMG. The chart displays the percentage of
rats in each group that had left hemidiaphragm recovery detected by EMG. Statistical
analysis consisted of data from 120 rats. A Chi-square test was performed and significance
was found between the proportions of observations (Yes/No) and the groups, X2 (9, N =
120) = 23.749, p = 0.005. The Fisher exact test found significance between the following
pairwise comparisons; 0.03mg/kg vs. 0.25mg/kg (p=0.033, #); 0.03mg/kg vs. WGA-HRPAuNP (p=0.001, #); 0.03mg/kg vs. 0.03 AuNP-proTHP (p=0.002, #); 0.07mg/kg vs. 0.03
AuNP-proTHP (p=0.009, +); 0.07mg/kg vs. WGA-HRP-AuNP (p=0.004, +); 0.14mg/kg vs.
0.03AuNP-proTHP (p=0.031, *); 0.14mg/kg vs. WGA-HRP-AuNP (p=0.026, *).
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Based on EMG data, the previously paralyzed hemidiaphragm can be stimulated
following injection of the nanoconjugate. The return of hemidiaphragm function can be
detected as early as day 2 post injection, and persists for the duration of the experiment,
up to and including day 14 post injection. All five nanoconjugate doses produced recovery
as detected by EMG.
Injection of control solutions containing saline, WGA-HRP-AuNP, or AuNP-proTHP
were unable to stimulate any detectable hemidiaphragm activity. Interestingly, the
remaining control solution proTHP dissolved in saline, injected intradiaphragmatically, did
result in activity detectable by EMG. However, with data only from the EMG, it is unclear as
to whether this is isolated muscle activity stimulated by the injection or proTHP (Bianchi
1961; Isaacson and Sandow, 1967; Kentera and Varagic, 1975; Jones et al., 1982; Creed
et al., 1983; Supinski et al., 1984), or if it is a return of function mediated by the bulbospinal
pathway via the phrenic nerve.
Phrenic nerve response to WGA-HRP-AuNP-proTHP and control solutions
Bilateral phrenic nerve recordings were used to quantify recovery on days 3, 7, and
14 following nanoconjugate injection of the three doses with the highest occurrence of
diaphragm recovery as characterized by EMG. See Methods for details.
One-way ANOVA showed significant drug effect on day 3 between the 0.14mg/kg
dose and the remaining two groups, 0.03mg/kg dose and 0.07mg/kg dose for the INT
(p<0.001) and the MAX (p<0.001) (Fig. 41, Table 6). This data suggests that at the day 3time point, the 0.14mg/kg dose nanoconjugate is the most effective at restoring LPN activity
with 5.1±0.8% INT and 8.2±1.4% MAX LPN recovery.
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Figure 41: Comparison of Day 3 Nerve Recordings. The average percent integrated (top
graph) and average percent maximum amplitude (bottom graph). Statistical data consisted
of neurograms from 21 rats (Table 6). One-way ANOVA showed significant drug effect on
day 3 between the 0.14mg/kg dose and the remaining two groups, 0.03mg/kg dose and
0.07mg/kg dose for the integrated waveform (p<0.001) and the maximal amplitudes
(p<0.001).
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Nanoconjugate Dose
Administered

Percent INT

Percent MAX

0.03mg/kg

0.4±0.2%

1.8±1.2%

0.07mg/kg

0.002±0.005%

0.2±0.7%

0.14mg/kg

5.1±0.8%

8.2±1.4%

Table 6: Left phrenic nerve percent recovery on day 3. The percent integrated (INT) and
percent maximum amplitude (MAX) of the left phrenic nerve compared to the right phrenic
nerve. Statistical data consisted of neurograms from 21 rats. One-way ANOVA showed
significant drug effect on day 3 between the 0.14mg/kg dose and the remaining two groups,
0.03mg/kg dose and 0.07mg/kg dose for the integrated waveform (p<0.001) and the
maximal amplitudes (p<0.001).

One-way ANOVA showed no significant drug effect on day 7 for either the INT or
the MAX (Fig. 42, Table 7). The dose 0.14mg/kg demonstrated the highest percent recovery
following nanoconjugate administration with 0.6±1.3% INT and 3.8±8.4% MAX LPN
recovery. The control solution 0.07mg/kg proTHP dissolved in saline, injected
intradiaphragmatically demonstrated 0.5±0.1% INT and 1.5±0.4% MAX LPN recovery. The
LPN signal was detected in the remaining two controls WGA-HRP-AuNP and AuNPproTHP, however the amount was negligible; 0.01±0.02% INT, 0.6±1.0% MAX and
0.004±0.01% INT, 0.3±1.0% MAX respectively.
One-way ANOVA showed significant drug effect on day 14 for the INT between the
0.03mg/kg dose and the 0.07mg/kg dose (p=0.042). The was also significant drug effect for
the MAX between the 0.03mg/kg dose and the remaining two doses 0.07mg/kg (p<0.001)
and 0.14mg/kg (p<0.001) (Fig. 43, Table 8). This data suggests that at the day 14-time
point, the 0.03mg/kg dose nanoconjugate is the most effective at restoring LPN activity with
2.3±0.9% INT and 7.9±2.2% MAX LPN recovery
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Figure 42: Comparison of Day 7 Nerve Recordings. The average percent integrated (top
graph) and average percent maximum amplitude (bottom graph). Statistical data consisted
of neurograms from 30 rats (Table 7). One-way ANOVA showed no significant drug effect
on day 7 for the integrated waveform or the maximal amplitudes.

83

Figure 43: Comparison of Day 14 Nerve Recordings. The average percent integrated
(top graph) and average percent maximum amplitude (bottom graph). Statistical data
consisted of neurograms from 17 rats (Table 8). One-way ANOVA showed significant drug
effect on day 14 for the integrated waveform between the 0.03mg/kg dose and the
0.07mg/kg dose (p=0.042). The was also significant drug effect for the maximal amplitudes
between the 0.03mg/kg dose and the remaining two doses 0.07mg/kg (p<0.001) and
0.14mg/kg (p<0.001).
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Administered Solution

Percent INT

Percent MAX

0.03mg/kg nanoconjugate

0.01±0.04%

0.3±0.9%

0.07mg/kg nanoconjugate

0.4±0.3%

2.3±1.9%

0.14mg/kg nanoconjugate

0.6±1.3%

3.8±8.4%

WGA-HRP-AuNP

0.01±0.02%

0.6±1.0%

0.03mg/kg AuNP-proTHP

0.004±0.01%

0.3±1.0%

0.07mg/kg proTHP

0.5±0.1%

1.5±0.4%

Table 7: Left phrenic nerve percent recovery on day 7. The percent integrated (INT) and
percent maximum amplitude (MAX) of the left phrenic nerve compared to the right phrenic
nerve. Statistical data consisted of neurograms from 30 rats. One-way ANOVA showed no
significant drug effect on day 7 for the integrated waveform or the maximal amplitudes.

Nanoconjugate Dose
Administered

Percent INT

Percent MAX

0.03mg/kg

2.3±0.9%

7.9±2.2%

0.07mg/kg

0.7±0.2%

2.3±0.9%

0.14mg/kg

0.6±1.7%

1.9±2.4%

Table 8: Left phrenic nerve percent recovery on day 14. The percent integrated (INT)
and percent maximum amplitude (MAX) of the left phrenic nerve compared to the right
phrenic nerve. Statistical data consisted of neurograms from 17 rats. One-way ANOVA
showed significant drug effect on day 14 for the integrated waveform between the
0.03mg/kg dose and the 0.07mg/kg dose (p=0.042). The was also significant drug effect for
the maximal amplitudes between the 0.03mg/kg dose and the remaining two doses
0.07mg/kg (p<0.001) and 0.14mg/kg (p<0.001).
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Based on statistical analysis of the neurograms, both the 0.14mg/kg and 0.03mg/kg
doses had a significant drug effect for different time points; day 3, day 14 respectively. This
variance may demonstrate the effect of proTHP over time.
To determine the effect of proTHP over time, the neurograms sampled for each dose
at the three time points, day 3, 7, and 14, were compared. The 0.03mg/kg dose group had
a total of 20 rats. One-way ANOVA showed a significant drug effect on day 14 for both the
integrated waveform and the maximal amplitudes p<0.001 (Fig. 44). This data suggests the
dose 0.03mg/kg does not have an immediate effect but is more effective over time.

Figure 44: Dose 0.03mg/kg Nerve Recordings. The average percent integrated (top
graph) and average percent maximum amplitude (bottom graph). Statistical data consisted
of neurograms from 20 rats. One-way ANOVA showed significant drug effect on day 14 for
both the integrated waveform or the maximal amplitudes p<0.001.
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The 0.07mg/kg dose group consisted of 14 rats. One-way ANOVA showed
significant drug effect for the integrated waveform on day 14 for both the integrated
waveform [day 3 vs. day 7 (p=0.003); day 3 vs. day 14 (p<0.001); day 7 vs. day 14
(p=0.014)], and the maximal amplitudes [day 3 vs. day 7 (p=0.048); day 3 vs. day 14
(p=0.003)] (Fig. 45). This data suggests the dose 0.07mg/kg, similar to 0.03mg/kg, is more
effective over time.

Figure 45: Dose 0.07mg/kg Nerve Recordings. The average percent integrated (top
graph) and average percent maximum amplitude (bottom graph). Statistical data consisted
of neurograms from 17 rats. One-way ANOVA showed significant drug effect for the
integrated waveform between all days sampled, day 3 vs. day 7 (p=0.003); day 3 vs. day
14 (p<0.001); day 7 vs. day 14 (p=0.014). The maximal amplitudes showed significance for
day 3 only; vs. day 7 (p=0.048); vs. day 14 (p=0.003).
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The 0.14mg/kg dose group consisted of 17 rats. One-way ANOVA showed
significant drug effect for the integrated waveform on day 3 for the integrated waveform
(p<0.001), but showed no significance for the maximal amplitudes (Fig. 46). This suggests
that the 0.14mg/kg dose has an immediate effect that wears off over time. Alternatively, the
decrease could be a result of overstimulation appearing as a decrease in LPN activity at
the later time points (Nantwi et al, 1996).

Figure 46: Dose 0.14mg/kg Nerve Recordings. The average percent integrated (top
graph) and average percent maximum amplitude (bottom graph). Statistical data consisted
of neurograms from 17 rats. One-way ANOVA showed significant drug effect for the
integrated waveform on day 3 for the integrated waveform (p<0.001), but showed no
significance for the maximal amplitudes.
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Discussion
Visualization
WGA-HRP was chosen as the transporter to mediate the selective uptake of the
nanoconjugate. This was accomplished by using the unique relationship between WGA and
receptors on the phrenic motoneuron axon terminals at the neuromuscular junction. The
role of HRP was to provide a method to visualize the WGA-HRP-AuNP component following
injection. Unfortunately, the chemical reactions to visualize HRP were inconsistent. There
was concern that the amount of HRP in the system was so miniscule, thus creating the
challenge to consistently detect HRP. In an effort to amplify the signal, a technique to bind
antibodies to the WGA component was implemented. The technique to visualize WGA
proved to be stable and reproducible as demonstrated by the study investigating the
DPCPX nanoconjugate (Minic et al., 2016). The establishment of a protocol to detect WGA
suggests that HRP is dispensable, i.e. it is not important for the uptake of WGA at the
phrenic neuromuscular terminals.
In this study, WGA was detected in the ipsilateral phrenic nuclei and bilaterally in
the rVRGs on day 3 post nanoconjugate injection. Due to the permanent amide bond
between WGA-HRP and AuNP, it is thought that the AuNPs are also located in the ipsilateral
phrenic nuclei and bilateral rVRGs. In an effort to determine the AuNPs location(s) post
injection, a biodistribution study is currently underway.
At this time, we are unable to visualize the proTHP portion of the nanoconjugate in
vivo. The ester bond was designed to release proTHP intracellularly, ideally within the
phrenic motoneurons and rVRG pre-motor neurons. The presence of proTHP would
stimulate these neurons, resulting in recovery of the diaphragm. It has been confirmed in a
solution of artificial cerebral spinal fluid, at a 12-hour time point, that the ester bonds are
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broken and proTHP has been released. Further studies to detail the release of proTHP, and
DPCPX, including release in a solution more similar to the intracellular environment and pH
are underway. In addition, a study to identify where in the cell the ester bond is broken is
being developed.
Interestingly in comparison to the WGA-HRP-AuNP-proTHP nanoconjugate, the
WGA-HRP-AuNP-DPCPX nanoconjugate was also detected bilaterally in the rVRGs but
was bilaterally detected in the PN (Minic et al., 2016). This is an interesting finding since
both experiments followed the same protocol. At day 7 post injection, the highest average
integrated waveform from the proTHP nanoconjugate was 0.55±1.3%, whereas the DPCPX
nanoconjugate produced a staggering 56.8±4.3% recovery. Moreover, on day 14 the
proTHP nanoconjugate produced 2.26±0.9% LPN recovery compared to the DPCPX
nanoconjugate with 72.4±7.3% LPN recovery. In the DPCPX study, the presence of WGA
in both phrenic nuclei, suggests the DPCPX nanoconjugate has greater mobility. This could
play a part in the notable effectiveness of the DPCPX nanoconjugate compared to the
proTHP nanoconjugate.
EMG analysis
The results from EMG analysis demonstrate that all five nanoconjugate doses were
able to stimulate recovery of LHD activity detected as early as day 2 post injection and
persisted up to 14 days. EMG results suggest the dose 0.03mg/kg to be most effective as
it produced a 65% recovery rate, higher than all remaining doses. Significance of the
recovery percent rate was detected in between the nanoconjugate groups, and two of the
controls WGA-HRP-AuNP and 0.03mg/kg AuNP-proTHP. As reported in the results,
sporadic (non-phasic) bursts were detected in the 0.12mg/kg and 0.14mg/kg groups, a
possible effect of over stimulation (Nantwi et al., 1996). In addition, several of the 0.14mg/kg
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dose rats presented difficulty when putting them under anesthesia for follow up procedures,
often requiring supplemental anesthesia injections before beginning the procedure. Both of
these observations suggest that 0.14mg/kg is over stimulating, or hyper-activating, the
respiratory system. Following injection of the highest nanoconjugate dose of 0.25mg/kg,
recovery was detected in 1 rat out of 7 (14%). The dose 0.25mg/kg resulted in the lowest
percent recovery, suggesting a suppression of respiratory system activity when a higher
dose of theophylline is administered (Nantwi et al., 1996).
The control solutions, WGA-HRP-AuNP and 0.03mg/kg AuNP-proTHP did not
produce LHD recovery in any of the rats tested. It is interesting to note that AuNP-proTHP
was unable to produce LHD recovery even though proTHP was present. The explanation
behind this remains elusive; one possibility is that without the WGA-HRP, AuNP-proTHP
remains within the muscle (extracellularly) until the conjugate is cleared. Remaining in the
diaphragm could prevent the degradation of the ester bond which is designed to dissociate
proTHP from AuNP in a pH similar to that found intracellularly, which is more acidic than
the extracellular environment (Adler et al., 1965; Deutsch et al., 1982).
Interestingly the intradiaphragmatic injection of proTHP dissolved in saline was able
to produce diaphragm activity in 40% of the rats, whereas saline alone was not. However,
upon further investigation, injecting theophylline into the muscle may provoke a systemic
response manifesting in muscle contractions (Bianchi 1961; Isaacson and Sandow, 1967;
Kentera and Varagic, 1975; Jones et al., 1982; Creed et al., 1983; Supinski et al., 1984). It
is important to point out that drug induced contractions within the diaphragm does not
equate phrenic nerve activity. Being able to provoke contractions of the diaphragm following
intradiaphragmatic injection of proTHP or the tripartite nanoconjugate highlights the
importance of characterizing recovery with EMG and phrenic nerve recordings.
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Bilateral Phrenic Nerve Recordings
To better understand the effect of the nanoconjugate, quantification of bilateral nerve
recordings under standardize conditions were compared between groups. Phrenic nerve
recordings detected bilateral phrenic nerve activity in all groups. Beginning with the nerve
recordings sampled on day 3, the 0.14mg/kg dose group produced a significantly greater
percent recovery for the average percent integrated waveform, and the maximum
amplitude. However, the average percent for the 0.14mg/kg integrated waveform was only
5.12±0.8% LPN activity compared to the RPN. On day 7, there was no significance
detected between experimental and control groups. The 0.14mg/kg group was again the
group with the highest integrated waveform, but the day 7 average integrated waveform
decreased to 0.55±1.3% LPN activity compared to the RPN.
Interestingly on day 14 the 0.03mg/kg dose demonstrated significantly greater
percent recovery than the 0.07mg/kg and 0.14mg/kg groups with an integrated waveform
of 2.26±0.9% LPN activity. The variations of percent recovery for the 3 nanoconjugate
doses over the course of the study might demonstrate the effect on respiration as proTHP
is metabolized over time. The 0.03mg/kg dose is 0.4±0.2% on days 3 and 7, then jumps up
to 2.3±0.9% on day 14. Similarly, the LPN percent recovery following a 0.07mg/kg dose is
barely detectable on day 3, followed by a significant increase in percent recovery that
continues to increase up to day 14. Conversely the 0.14mg/kg dose started out strong with
5.1±0.8% LPN recovery followed by a significant decline in activity for the remainder of the
study. This pattern following the 0.14mg/kg dose, could depict a strong response from the
initial proTHP exposure followed by an inhibitory effect in the subsequent days. The
inhibition of phrenic nerve activity following a high dose of theophylline has been described
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before (Nantwi et al., 1996; Nantwi et al., 2003b). However, this is the first time theophylline
appears to stimulate phrenic nerve activity followed by an inhibition of activity.
Considering the results for both the EMG and phrenic nerve recordings following
injection of the tripartite nanoconjugate and control solutions; it is possible that recovery
following nanoconjugate injection is the result of a systemic effect following
intradiaphragmatic injection, an effect of the release of proTHP in the PN and rVRGs
following WGA mediated endocytosis, or a combination of both. The rationale behind a
systemic effect is based on the observations following injection of the control proTHP in
saline that demonstrated a 40% occurrence of LHD recovery detected by EMG, and
0.5±0.1% LPN activity compared to the RPN on day 7. The results produced by injection
proTHP alone compared to the nanoconjugate at the same 0.07mg/kg dose, 57%
occurrence of LHD and 0.4±0.3% LPN activity on day 7, suggests the recovery observed
following nanoconjugate injection is primarily systemic. Visualization of WGA in the
ipsilateral phrenic nuclei and bilaterally in the rVRGs confirms that the WGA component is
able to mediate intracellular transport following injection, but the presence of proTHP in
these locations are not confirmable at this time.
Regardless of where or how proTHP is acting, a maximum integrated waveform of
5.12±0.8% LPN activity following nanoconjugate injection is poor recovery. Fortunately, in
addition to theophylline there are multiple drugs known to enhance respiration following high
SCI including DPCPX, a specific A1 adenosine receptor antagonist (Nantwi et al., 1996;
Goshgarian and Nantwi, 2001; Kajana and Goshgarian, 2008). As mentioned in the
previous section, simultaneous to this study, AuNPs conjugated to WGA-HRP and DPCPX
were being investigated. Injection of the DPCPX nanoconjugate produces an average
percent recovery of 56.8% on day 7 and 72.4% on day 14 for the integrated waveforms of
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the LPN compared to the RPN (Minic et al., 2016). Further investigation into the use of the
DPCPX nanoconjugate is underway as results are more promising than those detailed in
this study using proTHP.
Lastly, concerns about the high AuNP concentration of the proTHP nanoconjugate,
and possible AuNP aggregation preventing endocytosis, has led to an experiment to
investigate the rate of recovery following injection of greatly diluted proTHP nanoconjugate
solution. If there is an aggregation of AuNPs, preventing the uptake of the nanoconjugate,
reducing the concentration would reduce the chance of aggregation. This could increase
the WGA mediated uptake, increasing the amount of proTHP exposed to the PN and
rVRGs, in turn increasing the percent recovery of the LNP.
Notes on the synthesis of the theophylline nanoconjugate
Throughout this experiment the complexity of theophylline nanoconjugate synthesis
became apparent. In order to bind theophylline to the AuNPs a hydroxymethyl group was
added to the theophylline creating proTHP.

A short length of time between proTHP

synthesis and nanoconjugate synthesis was critical to make a functional nanoconjugate.
The final product, proTHP, was originally stored in small vials containing room air. Over time
the moisture in the air was able to dissociate the hydroxymethyl group, turning an unknown
amount of proTHP back to THP. This dissociation made the chemical reaction to bind
proTHP to the AuNPs less effective, resulting in various amounts of proTHP per AuNP. For
example, when comparing 2 nanoconjugate batches with thermogravimetric analysis (TGA)
a 5.697% weight variance was detected, which is the difference of 105 molecules of proTHP
per AuNP and a change in proTHP concentration by 0.22mg/ml. The instability of the
hydroxymethyl group made apparent the need to characterize every batch with TGA to
verify uniformity and the actual drug concentration. Confirming the drug concentration with
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TGA allows the appropriate adjustment in volume to ensure the reported dose is injected.
The integrity of post-synthesis (ester) bond stability has been emphasized by others
(Duncan and Gaspar, 2011), therefore It was decided to limit the use of the nanoconjugate
for no longer than one-month post synthesis. To further protect proTHP, a technique of
storing newly synthesized proTHP under a layer of argon gas to block moisture, was
implemented. Further investigation into the effects of the proTHP bound nanoconjugate
must employ all known methods to stabilize proTHP and must use methods such as TGA
to verify the actual nanoconjugate drug load. A consideration for future studies is the use of
a hydroxyethyl theophylline, commercially available from Sigma-Aldrich, in place of the
hydroxymethyl theophylline synthesized by our collaborators and used in this study. The
hydroxyethyl theophylline appears to be more stable than the hydroxymethyl theophylline
and could reduce drug load variance complications. Studies are currently underway to
determine differences between synthesis and the stability of nanoconjugates synthesized
with hydroxyethyl theophylline compared to hydroxymethyl theophylline.
Interestingly the synthesis of the WGA-HRP-AuNP-DPCPX nanoconjugate used in
the Minic et al., 2016 study did not encounter the same issues stated above. In comparison
to theophylline, DPCPX has an extra 5 carbon ring causing DPCPX to be more hydrophobic,
a characteristic that may contribute to the stability of DPCPX during nanoconjugate
synthesis.
Closing Statement
WGA-HRP-AuNP-proTHP nanoconjugates are capable of increasing the amount of
LPN recovery when injected intradiaphragmatically immediately after C2Hx. Targeting drug
delivery, reduces the therapeutic dose from 15mg/kg IV (Nantwi et al., 1996) to less than
0.2mg/kg. In doing so the restored left hemidiaphragm and left phrenic nerve function can
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be detected as early as day 2 and persists up to day 14 post injection. However, the WGAHRP-AuNP-proTHP nanoconjugate used in this study fails to induce the amount of recovery
following the administration of the WGA-HRP-AuNP-DPCPX nanoconjugate (Minic et al.,
2016).
Lastly, the application of the WGA-HRP-AuNP nanoconjugate is not limited to the
phrenic motor system. WGA-HRP has been utilized for decades to identify neuromuscular
pathways. In theory, injection of the WGA-HRP-AuNP nanoconjugate bound to a variety of
substances could hold promise for applications in multiple disease and injury models.

96

CHAPTER 3: APPLICATION OF THE THEOPHYLLINE BOUND NANOCONJUGATE IN
THE CHRONICALLY INJURED SPINAL CORD MODEL
Summary
The chronically C2Hx rat exhibits injury induced plasticity of physiologically active
synapses in the spinal cord and medullary respiratory centers. Over time, synaptic plasticity
results in multiple connections to numerous nuclei in addition to those identified in the acute
C2Hx model as demonstrated by WGA-Alexa 488 labeling (Buttry and Goshgarian, 2014).
Due to the retrograde transsynaptic transport of WGA, following intradiaphragmatic
injection, the nanoconjugate is expected to deliver the drug to the additional nuclei identified
in the chronically C2Hx model. Following nanoconjugate injection, a variable effect in the
descending respiratory drive was observed. However, the full effect of the proTHP bound
nanoconjugate in the chronically C2Hx model remains uncertain due to the complex
environment post injury and variability between individuals.
Introduction
Of the estimated 276,000 people living in the United States only 4.5% (12,500
people) are people with new injuries, meaning the vast majority have a chronic injury
(NSCISC, 2015). In order for a drug therapy to be considered clinically, administration in
chronically injured individuals must be considered as well as in the acutely injured. In this
study chronically injured rats were defined as 12 weeks post C2Hx. This time frame
provided an adequate recovery period for the central nervous system in the rat C2Hx injury
model to adapt to the SCI (Nantwi et al., 1999; Golder et al., 2001b; Nantwi et al., 2003a;
Fuller et al., 2008; Buttry and Goshgarian, 2014). It is well known that in the chronically
C2Hx injury model the respiratory pathway, as well as accessory pathways discussed in
Chapter 1, are in a hyperactive state (Goshgarian,1979). This is critical information since
the therapeutic dose (15 mg/kg theophylline, systemically administered) that stimulates
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phrenic nerve activity in the acutely C2Hx rat has been shown to inhibit phrenic motor output
when administered to the chronically C2Hx rat (Nantwi et al., 2003a). Moreover, reducing
the dose in the chronically C2Hx rats to 5 mg/kg or 2.5 mg/kg also inhibit phrenic nerve
output or have no effect (Nantwi et al., 2003a).
To characterize functional recovery in the chronically C2Hx rats flowing
nanoconjugate injection, EMG analysis and phrenic nerve recordings were used as
described in Chapter 2 (see methods for additional details). In previous studies
spontaneous functional recovery of the diaphragm has been documented following C2Hx
(Nantwi et al., 1999; Golder et al., 2001; Nantwi et al., 2003a; Fuller et al., 2008). However,
based on the method of measurement, the time frame in which the spontaneous recovery
occurs varies. In the Chapter 1 chronic studies, EMG recordings immediately prior to
intradiaphragmatic tracer injections indicated spontaneous functional recovery of the
diaphragm in 62% of the rats at the time point of 7 weeks post C2Hx or more. Also
demonstrated in the Chapter 1 studies, in chronically injured rats, there is a change in the
physiologically active synapses temporally associated with the activation of the diaphragm
following a C2Hx based on the change in pattern of WGA-Alexa 488 labeling following
intradiaphragmatic injection. In this study the nanoconjugate was applied to the chronic
C2Hx injury model with the expectation of WGA mediated transport of the nanoconjugate
to the nuclei observed in the Chapter 1 chronic C2Hx injury model. Plasticity of
physiologically active synapses in the chronically C2Hx system has the potential to change
the distribution of the nanoconjugate due to the properties of WGA receptor mediated
transsynaptic transport. The change in proTHP distribution could induce recovery following
12 weeks post C2Hx or strengthen the spontaneously developed recovery. In contrast, the
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nanoconjugate could have an inhibitory effect similar to systemic administration, blockading
the descending drive in chronic C2Hx rats as demonstrated by Nantwi et al., 2003a.
Physiological response to WGA-HRP-AuNP-proTHP
The chronic study was comprised of data from 27 C2Hx rats. After a 12-week
recovery period all rats underwent a second EMG to test for spontaneous recovery prior to
the injection of nanoconjugate. See methods for details.
Each rat underwent an EMG 3 to 6 days following nanoconjugate injection. Based
on the EMG results, each rat was placed into a “Recovery/Improvement” or “No
change/Loss” category. Recovery was defined as a return of diaphragm activity when prior
to nanoconjugate injection there was a complete absence of diaphragm activity, i.e. no
spontaneous recovery. An improvement upon spontaneous recovery was defined as activity
appearing in 1 or more of the 3 diaphragm areas in addition to spontaneous activity. No
change was defined as no observable activity regained in 1 or more of the 3 areas following
injection. Lastly, a loss was defined as a loss of spontaneous activity in 1 or more of the 3
areas of the diaphragm following nanoconjugate injection. Five of the 12 rats (41.67%)
resulted in improvement following injection of the nanoconjugate at the dose 0.07mg/kg. In
an effort to increase the amount of rats that exhibited improvement following nanoconjugate
administration, the dose was lowered to 0.06mg/kg. However, 0.06mg/kg resulted in
improvement in 1 of 5 rats (20%). The last group to be tested received a dose of 0.02mg/kg,
and resulted in improvement in 3 of 16 (18.75%). Similar to the EMG analysis in Chapter 2,
the occurrence of “Recovery/Improvement” or “No change/Loss” were compared to
determine the dose that produced the most recovery or improved upon existing
spontaneous recover, however no significance was detected (Fig. 47).
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Figure 47: Chronic C2Hx model EMG response to nanoconjugate dose. At 12 weeks
post C2Hx three groups were created based on the nanoconjugate dose injected:
0.02mg/kg (N=16), 0.06mg/kg (N=5), and 0.07mg/kg (N=4). Each rat underwent a second
EMG in the days following injection. In the above graph groups are sub-divided into a
“Recovery/Improvement” or “No change/Loss” category based on return of function or an
improvement of spontaneous activity or no change or a loss of spontaneous activity. The
percent of recovery/improvement for the three nanoconjugate doses were compared, no
significance was found suggesting that proTHP has no effect on chronic animals.
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Bilateral phrenic nerve recordings were sampled at 13 weeks (day 7 post
nanoconjugate injection). Groups were compared to determine the dose that produced the
most recovery or improvement upon existing spontaneous recovery; 0.02mg/kg (N=10),
0.06mg/kg (N=3), and 0.07mg/kg (N=3). One-way ANOVA with Holm-Sidak pairwise
comparison showed a significant dose effect between the groups (p=<0.001). Pairwise
comparison showed significance between the 0.06mg/kg dose and the remaining two
doses, 0.02mg/kg and 0.07mg/kg for both the integrated waveform (p<0.001) and maximal
amplitudes (p<0.001) (Fig. 48). This suggests that on day 7 post nanoconjugate injection
the 0.06mg/kg dose produces a higher percentage of left phrenic nerve activity than the
remaining two doses.
Influence of spontaneous activity on recovery
At 12 weeks post C2Hx, 22 of the 27 rats had spontaneous activity, prior to
nanoconjugate injection, detected by EMG. The WGA component of the nanoconjugate is
activity dependent and requires muscle activity of the diaphragm to undergo receptor
mediated endocytosis. Rats that had spontaneous activity prior to injection at 12 weeks post
C2Hx could have an advantage over rats with no spontaneous activity. Interestingly analysis
of the occurrence of “Recovery/Improvement” vs. “No change/Loss” based on EMG
recordings showed no significance for all 3 doses; 0.02mg/kg, 0.06mg/kg, and 0.07mg/kg.
However, the data from the phrenic nerve recordings revealed that the 0.2mg/kg dose group
showed significance with the One-way ANOVA with Holm-Sidak pairwise comparison
(p=<0.001) for the integrated waveform (p<0.001), but not for the maximal amplitudes
(p=0.003) (Fig. 49).
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Figure 48: Nerve recording dose comparison in chronically C2Hx. Comparison of the
average percent integrated (top graph) and average percent maximum amplitude (bottom
graph) for the chronic groups. Statistical data consisted of neurograms from 17 rats. Oneway ANOVA with Holm-Sidak pairwise comparison showed significant dose effect between
the groups (p=<0.001). Pairwise comparison showed significance between the 0.06mg/kg
dose and the remaining two doses, 0.02mg/kg and 0.07mg/kg for both the integrated
waveform (p<0.001) and maximal amplitudes (p<0.001).
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Figure 49: Effect of spontaneous recovery on nerve recordings in nanoconjugate
injected chronically C2Hx rats. Comparison of the average percent integrated (top graph)
and average percent maximum amplitude (bottom graph) for the chronic group that received
the 0.02mg/kg dose. Statistical data consisted of neurograms from 8 rats. One Way ANOVA
with Holm-Sidak pairwise comparison showed significant effect between rats with
spontaneous recovery vs. those with no spontaneous recovery (p=<0.001). Pairwise
comparison showed significance between groups for the integrated waveform (p<0.001),
but not for the maximal amplitudes (p=0.003).
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Discussion
Application of any drug intended to increase respiratory drive following SCI must be
characterized in both the acute and chronically injured systems. There are numerous
differences in the spinal cord and medulla following injury including changes in cell to cell
connections (Lane et al., 2009; Buttry and Goshgarian, 2014) and how respiration reacts to
drug intervention (Nantwi et al., 2003a). Plasticity of physiologically active synapses in the
chronically C2Hx system, as discussed in Chapter 1, has the potential to change the
distribution of the nanoconjugate due to the properties of WGA receptor mediated
transsynaptic transport (Buttry and Goshgarian, 2014). Qualitative analysis of the
occurrence of recovery or

improvement upon spontaneous recovery following

nanoconjugate injection produced no significance between the doses injected. However
quantitative analysis of phrenic nerve recordings reported a significant increase in the
amount of left phrenic nerve (LPN) activity following injection of the 0.06mg/kg dose
compared to 0.02mg/kg and 0.07mg/kg. In addition, chronic rats that had spontaneous
activity as determined by EMG analysis at 12 weeks post-op followed by injection of
0.02mg/kg had a significant increase in the amount of LPN activity compared to rats without
spontaneous activity at 12 weeks post-op followed by injection of 0.02mg/kg
nanoconjugate. This suggests that the amount of activity present prior to injection may
influence the effectiveness of the activity dependent WGA mediated endocytosis. Increased
WGA mediated endocytosis of the nanoconjugate would increase the targeted release of
proTHP, resulting in a higher delivered drug concentration.
The chronic results suggest that the targeted drug delivery nanoconjugate based
approach can be applied to the chronic system to stimulate LPN activity. The chronic study
consisted of 27 rats and just scratched the surface of the work required to fully characterize
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the nanoconjugate in the chronically injured system. Further investigation of the doses
reported in this study as well as control solutions are needed to move forward with chronic
applications.

105

OVERALL SUMMARY
The studies presented in Chapter 1 examined the respiratory pathways prior to and
after a cervical SCI. First, utilizing the selective, activity dependent uptake of WGA (Harrison
et al., 1984, 1986; Jankowska, 1985; Schwab et al., 1979), spinal cord and brain stem nuclei
were identified with a fluorescent neuronal tracer, WGA-Alexa 488. WGA-Alexa 488 has an
advantage over the traditionally used WGA-HRP since the Alexa 488 portion is readily
identified with fluorescent microscopy. Eliminating the need for chemical reactions to
visualize HRP has provided a method to visualize the neurons responsible for diaphragm
activity while maintaining the integrity of the tissue for further biochemical or molecular
analysis.
Injection of WGA-Alexa 488 into the ipsilateral hemidiaphragm following a C2Hx
resulted in bilateral labeling of the phrenic motoneurons in the cervical spinal cord as well
as the premotor rVRG neurons in the medulla. However, following WGA-Alexa 488
exposure to the isolated ipsilateral phrenic nerve following a C2Hx, labeling was only
identified in the ipsilateral phrenic nuclei. This observation suggests that WGA-Alexa 488
must be exposed to the phrenic axon terminal at the neuromuscular junction in order for
transsynaptic transport to occur.
Once the labeling properties of WGA-Alexa 488 were identified and found to be
reproducible in the acute C2Hx model, the tracer was then characterized in the chronically
injured system. Following a C2Hx, the ipsilateral diaphragm is paralyzed with the exception
of intermittent activity stimulated by the crossed phrenic pathway (CPP). Over time the
diaphragm can regain phasic activity, this is referred to as spontaneous recovery (Nantwi
et al., 1999). Since the CPP circuitry is already in place, it would seem that spontaneous
recovery is a result of strengthening the CPP. To determine the nuclei associated with
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spontaneous recovery, rats underwent a C2Hx followed by a 12-week recovery period. At
12-weeks WGA-Alexa 488 was injected into the ipsilateral hemidiaphragm. Interestingly not
only was WGA-Alexa 488 identified bilaterally in the phrenic nuclei and the rVRGs but was
also identified in numerous spinal cord and brain stem nuclei. The change in labeling
demonstrates injury induced plasticity following SCI. Many of the labeled nuclei have been
linked to respiration as motor nuclei for accessory respiratory muscle, or nuclei that help
regulate and coordinate respiration with body functions. Therefore, the presence of WGAAlexa 488 in the nuclei (forelimb motoneurons, RST, DSCT, and VSCT) unique to the
chronically injured model is likely caused by hyperactivity of existing pathways. WGA-Alexa
488 labeling in the medulla for the acutely C2Hx and chronically C2Hx were strikingly
different. The acutely C2Hx rats displayed WGA-Alexa 488 labeling isolated to the rVRGs.
However, the chronically C2Hx rats, in addition to the rVRGs, displayed labeling in the
raphe, hypoglossal, spinal trigeminal, parvicellular reticular, gigantocellular reticular, and
intermediate reticular nuclei. All of these have been previously demonstrated, using
alternative tracers, to be associated with respiratory control in acutely hemisected or noninjured rats. It is important to point out that WGA-Alexa 488 only labels these nuclei in the
chronically injured system. This further emphasizes the selective activity-mediated uptake
of WGA bound conjugates.
Similar to the chronically C2Hx rats, the sham C2Hx rats also displayed bilateral
WGA-Alexa 488 labeled interneurons primarily in laminae VII and VIII of the cervical and
thoracic cord and bilateral labeled intercostal motoneurons in the thoracic spinal cord.
These results imply that the sham C2Hx surgery including laminectomy of C2, durotomy,
and laparotomy had an impact on the spinal cord environment. Interestingly, the supraspinal
nuclei appeared unaffected by the sham C2Hx and presented WGA-Alexa 488 labeling
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indistinguishable from the acute C2Hx rats. Thus, we can conclude that hemisection of the
spinal cord induces changes in the supraspinal circuitry. The use of WGA-Alexa 488 as a
neuronal tracer to detect changes in physiologically active synapses post injury proves to
be a valuable tool to identify areas of injury induced plasticity.
In the last study of Chapter 1, WGA-Alexa Fluorochromes were administered to
acutely C2Hx and non-injured rats by intradiaphragmatic and intrapleural injections.
Intrapleural injections were investigated as an alternative method to the invasive procedure
required to administer intradiaphragmatic injections. Following intrapleural injection, the PN,
intercostal SC nuclei, rVRGs, and unexpectedly the nucleus ambiguus (NA) were all
bilaterally labeled. A direct connection from the NA to the PN has yet to be defined,
suggesting that WGA-Alexa fluorochromes are capable of undergoing transsynaptic
transport across at least 2 synapses. This finding is of interest especially in respect to the
application of WGA-Alexa in the chronically injured system. Understanding the order of
activation may help determine the role each nuclei plays in spontaneous recovery. The
availability of neuronal tracers capable of crossing one, multiple, select, or all synapses
allows investigators to implement these techniques to ask questions related to neuronal
synapses and changes following injury and treatment.
In the final two chapters, following an acute or chronic SCI, a novel nanoconjugate
was administered to stimulate activation of the phrenic nuclei and diaphragm. Following a
C2Hx there is a loss of ipsilateral hemidiaphragm function. In the rodent injury model
adenosine antagonists, such as theophylline, are able to stimulate the functionally latent
CPP and restore hemidiaphragm function. However, in humans the therapeutic dose of
theophylline results in hyperactivity of many non-target nuclei. To reduce the administered
dose, theophylline was conjugated to the neuronal tracer WGA-HRP, using a gold

108

nanoparticle (AuNP) as a coupler. Following intradiaphragmatic injection of the tripartite
nanoconjugate, WGA-HRP is expected to mediated endocytosis at the axon terminal of
phrenic motoneurons. Once the nanoconjugate is endocytosed, the transient ester bond
linking the drug to the AuNP is degraded, freeing the drug. By targeting the drug to only the
neurons associated with diaphragm function, the dose needed to stimulate hemidiaphragm
activity is greatly reduced.
To investigate the effectiveness of the tripartite nanoconjugate in the acutely injured
system, rats were subjected to a C2Hx followed by intradiaphragmatic injection of the
theophylline bound nanoconjugate. Although the nanoconjugate was able to induce
recovery at the level of the phrenic nerve and the diaphragm, the amount of recovery was
rather small with a maximum average percent recovery of 5.12±0.8%.
It is known that the nanoconjugate is able to undergo receptor mediated
endocytosis, due to identification of the WGA portion of the nanoconjugate post injection in
the phrenic nucleus and rVRGs. However, the amount of nanoconjugate uptake needs to
increase. Several areas for improvement have been identified, including the injection of a
diluted nanoconjugate solution to determine if aggregation of the AuNPs are creating an
issue with uptake. These studies are planned and are not within the scope of this
dissertation. Regardless of the complications with the theophylline version of the
nanoconjugate, it is still important to point out that the nanoconjugate is capable of
undergoing WGA mediated endocytosis followed by transsynaptic transport. There are
numerous options as to what drug can be bound to the AuNPs. For example, replacing
proTHP with DPCPX induces a superior recovery of LPN activity.
Lastly, the final chapter examines the application of the tripartite nanoconjugate in
the chronically C2Hx rat model. The WGA-Alexa 488 chronic study provided an
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exceptionally detailed anatomical picture of the spinal and supraspinal nuclei that undergo
injury induced plasticity and synaptic activity modification. Based on WGA mediated uptake,
the nanoconjugate is expected to undergo transport to the nuclei identified with WGA-Alexa
488 in the chronic C2Hx model. The chronically injured system has remained challenging
to work with and responds differently to drugs than the acutely injured system (Nantwi et
al., 2003a). The 0.06mg/kg dose showed a significant effect over the remaining two doses
based on phrenic nerve recordings. However, rats with spontaneous recovery of the
diaphragm also showed a significant advantage over those with no spontaneous recovery
when comparing the average percent integrated waveforms. Endocytosis of WGA has been
shown to be activity dependent. Thus suggesting rats exhibiting spontaneous recovery
following chronic injury would have enhanced transport of the nanoconjugate, increasing
drug exposure. Application of the tripartite nanoconjugate in the chronically injured system
requires additional in-depth investigations to fine tune the drug dose, AuNP concentration,
and alternative drugs. With these findings, utilizing WGA to selectively deliver drugs has
potential clinical applications to increase respiratory output following SCI.
These studies show that WGA is able to selectively transport WGA-bound
conjugates, specifically Alexa fluorochromes and drug bound AuNPs, to nuclei that regulate
diaphragm function in the non-injured and acutely and chronically C2Hx rat models. In
addition to the respiratory motor pathway, WGA has been investigated in numerous
neuronal pathways. The findings presented here, have the potential for applications in any
system demonstrated to facilitate the selective uptake of WGA.
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MATERIALS AND METHODS
Animal Use
Adult male Sprague Dawley rats were used in these studies. All animal studies were
approved by the Wayne State University School of Medicine Institutional Animal Care and
Use Committee.
Second Cervical Segment Spinal Cord Hemisection (C2Hx)
All rats were injected with atropine sulfate (0.04mg/kg, im) 10 minutes prior to
anesthesia induction to reduce mucus secretions during the subsequent aseptic survival
surgery. Anesthesia was a mixture of ketamine (70mg/kg, ip) and xylazine (7mg/kg, ip).
After anesthesia induction, bupivacaine (2mg/kg, sc) a local anesthetic was injected into
the dorsal neck. The dorsal aspect of the neck was shaved and prepared for aseptic
surgery. An incision was made on the dorsal neck to expose the second cervical vertebra
(CV2). The paravertebral muscles were cut and retracted along the midline axis. All muscle
attachments to CV2 were cut to expose the spinous processes, laminae, and the
intervertebral space between CV1/CV2 and CV2/CV3. A bilateral laminectomy was
completed at the level of CV2 to expose the spinal cord. A durotomy was performed with
spring micro-scissors. After locating the C2 and C3 dorsal roots, the left half of the spinal
cord was cut just to the left of midline and continued to the lateral aspect of the cord caudal
to the C2 dorsal root. Care was taken to avoid cutting the large dorsal blood vessel that
typically courses along the midline of the spinal cord. The location of the hemisection also
avoids the anterior spinal artery on the ventral aspect of the spinal cord. The functional
completeness of the injury was confirmed with EMG of the diaphragm (see EMG Analysis).
The dorsal neck muscles were closed using 4-0 absorbable sutures (Vicryl, Ethicon)
followed by wound clips (Reflex® 9mm) for the skin. Following the cleaning of the cervical
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incision, the rats were injected with Buprenorphine (0.01mg/kg, sc) in 10ml saline for pain
control and yobine (2mg/kg, ip) to reverse xylazine. The following 48 hours, post-operative
rats were given additional injections of Buprenorphine (0.01mg/kg, sc) every 8-12 hours for
pain management. The rats recovered on a heating blanket on their back to limit pressure
on the diaphragm. When the rats were able to ambulate, they were returned to clean litterlined cages with food and water provided ad libitum on the floor of the cage to minimize
neck movement during recovery. The rats were also given peanut butter and cereal as an
enticement to eat.
Sham Second Cervical Segment Spinal Cord Hemisection
Rats underwent an identical hemisection surgical procedure described above up to
and including the durotomy, but the spinal cord was not cut.
Electromyography Analysis
Immediately following the left C2Hx or sham C2Hx, paralysis of the ipsilateral
hemidiaphragm was confirmed by EMG analysis. The abdominal surface of the diaphragm
was exposed by a 6-8 cm horizontal incision made approximately 0.5 cm caudal and parallel
to the costal margin. Bipolar platinum wire electrodes (Grass F-E2) were inserted
intramuscularly within each side of the diaphragm to detect muscle activity. Signals were
amplified (20,000X) and band pass-filtered (30Hz-3kHz) by Grass amplifiers (model P511
AC, Astro-Med, Inc., West Warwick, RI) and raw EMG signals were recorded by a
Cambridge Electronic Design (CED, Cambridge, England) data acquisition system
integrated with CED Spike 2® software. Recordings were taken from three areas of the left
hemidiaphragm: anterior (sternal), lateral (costal) and posterior (crural). Only rats that
showed a complete absence of activity in all three areas were included in the study.

112

In all chronic rats a second EMG to test for spontaneous recovery was assessed
immediately prior to the injection of WGA-Alexa fluor conjugates, nanoconjugate, or control
solutions.
Rats that received a nanoconjugate or control solution were assessed with EMG
analysis an additional 1-3 times depending on the length of the experiment. All subsequent
EMG recordings were performed under ketamine/xylazine anesthesia while spontaneously
breathing.
Following the EMG, the abdominal cavity was closed using 4-0 absorbable sutures
(Vicryl, Ethicon) followed by wound clips (Reflex® 9mm) for the skin. Postoperative care for
the first 48 hours was identical to the care described above after C2Hx.
Acute Studies
Acute is defined as up to 14 days following SCI. Dependent on the study, rats
survived a minimum of 48 hours or up to 14 days.
Chronic Studies
Hemisected rats recovered for a period of at least 7 weeks with no intervention with
respect to respiratory function. Several rats required medical attention for issues such as
wounds associated with the incision site or eye, or autophagy of the right hind paw. When
needed and as prescribed by the veterinarian, topical application of triple antibiotic ointment,
silver sulfadiazine, or Columbia powder was used to manage wounds. In addition,
Buprenorphine (0.01mg/kg, sc) or Carprofen (5mg/kg, sc) was administered for pain
management. To prevent autophagy of the right rear paw a topical mixture of New Skin and
metronidazole (500mg/mL MP Biomedicals 0215571005) was applied to the right rear paw
weekly (Zhang et al., 2001). Prior to implementing the topical paw treatment, several rats
had to be euthanized prior to completion of the study due to the severity of rear paw wounds.
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Intradiaphragmatic injections of WGA-Alexa fluor conjugates
Intradiaphragmatic injections of WGA-Alexa fluor conjugates were administered; i)
following a laparotomy to expose the abdominal surface of the diaphragm (non-injured), ii)
following EMG confirmation of hemidiaphragm paralysis (acutely injured), iii) following an
EMG at 12 weeks post C2Hx (chronically inured). All injections were administered using a
28 gauge Hamilton syringe (catalog # 7637-01, and # 7803-02). Rats were injected with
either 2% WGA- Alexa 594 (Life Technologies Cat. # W11262) saline solution or 2% WGAAlexa 488 (Life Technologies Cat. # W11261) in saline solution into the left hemidiaphragm.
A total of 50µl was administered to each rat in 10µl increments. The amount of tracer
injected was based on a previous study (Moreno et al., 1992) which determined that five
10µl injections distributed from the anterior to posterior region of the hemidiaphragm were
sufficient to label the phrenic nucleus that spans the C3-C6 segments of the cervical spinal
cord. All rats were sutured as described in the EMG analysis section and survived for 48
hours.
Intradiaphragmatic injections of nanoconjugate or control solutions
A detailed description of the synthesis of the proTHP nanoconjugates can be found
in the following manuscript: “Transporter protein and drug-conjugated gold nanoparticles
capable of bypassing the blood-brain barrier” Zhang et al., 2016. Intradiaphragmatic
injections of the nanoconjugate or a control solution; i) WGA-HRP-AuNP, ii) AuNP-ProTHP,
iii) ProTHP were administered following EMG confirmation of hemidiaphragm paralysis
(acutely injured), or following an EMG at 8-12 weeks post C2Hx (chronically inured). All
injections were administered using a 28 gauge Hamilton syringe (catalog # 7637-01, and #
7803-02). The total volume of the solution injected was weight based and dependent on the
concentration of the drug in the solution. Volume of the control solutions were calculated

114

identical to the drug based solutions to eliminate variance based on volume. All solutions
were injected in 10µl increments or less and were distributed from the anterior to posterior
region of the hemidiaphragm (Fig. 50). Following injection, the needle was slowly retracted
to prevent any leaks at the injection site. Rats survived for 3-14 days depending on the
timeline for each experimental group.

Figure 50: Intraoperative view of nanoconjugate injection sites. Exposure of the
abdominal surface of the left hemidiaphragm following injections of the WGA-HRP-AuNPproTHP nanoconjugate into the left hemidiaphragm. Injection sites are clearly visualized
due to the black coloration of the nanoconjugate solution.
Intact Phrenic Nerve Soak
Rats received a soak treatment of 2% WGA-Alexa 488 applied to the isolated left
phrenic nerve for 1 hour immediately after a C2Hx or sham surgery. The cervical phrenic
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nerve was approached ventrally and isolated from the underlying brachial plexus with fine
forceps and cotton swabs. The sheath of the nerve was carefully removed with fine forceps.
Photographic images of the nerve were captured at 40X on an Olympus C-5050 digital
camera attached to a Zeiss surgical microscope (Fig. 8). A cup created by cutting off the
bottom of a 1.5ml microcentrifuge tube was placed under the phrenic nerve. Small pieces
of bench top paper were placed around the cup to absorb fluid produced by the surrounding
tissue during the 1-hour treatment. 1.5µl of 2% WGA-Alexa 488 were placed in the cup with
a micropipette. The surgical field was covered with a piece of gauze moistened in sterile
saline to prevent tissues from drying out during treatment. After 1 hour, the remaining WGAAlexa 488, the cup and the bench paper was removed and the area was gently swabbed to
remove excess fluid. The muscles were sutured with 4-0 absorbable suture (Vicryl, Ethicon)
followed by 4-0 non-absorbable nylon suture (Ethilon, Ethicon) to close the skin. The rats
survived for 48 hours.
Intrapleural Injection
Rats received a transcutaneous intrapleural injection administered through the fifth
intercostal space into the thoracic cavity on the right side as described by Mantilla et al.,
2009. All rats received 50µl of 2% WGA-Alexa 488 saline solution administered with a 25
gauge by 5/8” needle syringe (Buttry and Goshgarian, 2015). It is important to note that
advancing the needle too far will result in an injection into the lung parenchyma.
Vagus Nerve Injection
The right vagus nerve was exposed by an incision of the ventral neck. The vagus
nerve was identified based on the anatomical relationship with the jugular vein and the
carotid artery. A Hamilton syringe was used to inject 1µl of a neuronal tracer into the right
vagus nerve; rats were injected with 5% True blue chloride (TB, Santa Cruz Biotechnology,
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Inc. Cat. # sc-216026) aqueous solution, or a 2% WGA-Alexa 594 (Life Technologies Cat.
# W11262) saline solution. The surrounding area was examined for any signs of leakage.
The neck muscles were sutured with 4-0 absorbable sutures (Vicryl) followed by closure of
the skin with 4-0 non-absorbable nylon sutures (Ethilon).
Tissue preparation of WGA-Alexa fluor conjugate injected rats
Forty-eight hours after injections, rats were anesthetized with urethane (1.6 g/kg, ip)
and transcardially perfused with 150 mL saline followed by 300 mL of 4% paraformaldehyde
in 0.1M phosphate-buffered saline (pH 7.4). The spinal cord (cervical through thoracic) and
medulla were removed and an insect pin was inserted along the longitudinal axis of both on
the left to differentiate the left from the right side. The medullary and spinal tissue was then
post-fixed in the perfusate overnight and cryoprotected 2-3 days in 30% sucrose in 0.1M
PBS until the tissue sank. Transverse, horizontal, or sagittal sections through the medulla
and spinal cord were cut in 40µm thick sections with a cryostat and collected in 0.1M PBS.
Every section from the medulla was saved, whereas every 3rd spinal cord section was
saved. Sections were then washed in 0.1M PBS and mounted on Poly-L-lysine treated
slides. The sections were cover slipped with Fluoromount (Sigma cat. # F4680) and
examined with a Zeiss Axiophot fluorescent microscope using the 488 filter (green), 594
filter (red), and the Dapi filter (blue). Images were captured using the Axio Vision Rel. 4.8
Program.
Autofluorescence is not problematic when examining WGA-Alexa tracers due to the
distinct granulation within the WGA-Alexa labeled cells (Goshgarian and Buttry, 2014).
However, True blue labeled cells have a hazy appearance throughout the cell body. To
reduce the chance of counting false positive True blue labeled cells, images were captured
with exposure times that resulted in a dark background. For cell counts, cells were
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considered labeled with True blue if the cell body was clearly identifiable and brightly
illuminated compared to the dark background. Cells were considered labeled with WGAAlexa fluor conjugate if the cell body was clearly identifiable and displayed granulation
characteristic of the tracer. Neurons labeled with WGA-Alexa fluor conjugates are
exceptionally bright and can be easily seen at low magnification. Positively labeled neurons
always have distinct granules that can be seen clearly at higher magnification. Non-labeled
neurons do not display granulation with in the cell boundaries. Cells on every other section
from the medulla were counted since every section was saved after sectioning the tissue;
this was to avoid counting the same cell body twice. Since every 3rd section from the spinal
cord was saved, cells were counted on every spinal cord section saved. A cell was
considered labeled if the cell body with a nucleus was identifiable.
Bilateral Phrenic Nerve Recordings/Electrophysiology
The groups designated for bilateral phrenic nerve recordings included rats with
varying doses of nanoconjugate, and rats that received injection of one of the control
solutions; i) WGA-HRP-Au, ii) AuNP-ProTHP, iii) WGA-HRP-AuNP-ProTHP intravenous, iv)
proTHP intradiaphragmatic. Bilateral phrenic nerve recordings were sampled at day 3, 7,
and 14 for acute studies and at 13 weeks for chronic studies. The rats were injected with
atropine sulfate (0.06mg/kg, im) 10 minutes prior to anesthesia induction to reduce mucus
secretions during the procedure. The initial dose of anesthesia was a mixture of ketamine
(70mg/kg, ip) and xylazine (7mg/kg, ip). A supplement of ketamine (17mg/kg, ip) and
xylazine (2mg/kg, ip) was provided as needed. The femoral vein was cannulated for drug
and fluid delivery. The femoral artery was cannulated to monitor blood pressure (World
Precision Instruments, #SYS-BP1). The blood pressure was maintained in the range of 90105 mmHg by injection of Lactated Ringer’s (Baxter) as needed. The right and left phrenic
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nerve were exposed by an incision to the ventral neck. The phrenic nerves were dissected
from the underlying brachial plexus and carefully de-sheathed with fine forceps and cotton
swabs. The right and left vagus nerves were dissected and the trachea was dissected to
prepare for a tracheotomy. The rats were ventilated with a mixture of room air and oxygen.
A bilateral vagotomy and phrenicotomy was performed. The phrenic nerves were cut to
eliminate afferent activity. The proximal portions of the cut right and left phrenic nerves were
then placed on bipolar platinum electrodes (Grass F-E2). Signals were amplified (20,000X)
and band pass-filtered (30Hz-3kHz) by Grass amplifiers (model P511 AC, Astro-Med, Inc.,
West Warwick, RI), raw and integrated signals were recorded by a Cambridge Electronic
Design (CED, Cambridge, England) data acquisition system integrated with CED Spike 2®
software. Once the phrenic nerves were stable in the setup, standardized conditions were
achieved. The rats were paralyzed with pancuronium bromide (0.5mg/kg iv); and the apneic
threshold was determined. To determine the apneic threshold (the lowest PaCO2 at which
a subject will remain apneic (temporary stop breathing)), the ventilator frequency was slowly
turned up until the phrenic nerve signal disappeared (ventilator is doing all the work and the
system is flooded with O2 therefore the brain stem does not need to send a signal to
contract diaphragm/breath and rid the body of CO2). The ventilator was then turned down
slowly until the recruitment threshold was found and the rat began to breathe again (bursting
signal re-appears on neurogram). The CO2 level was maintained at the recruitment
threshold, 3 to 5 mmHg above the apneic threshold (Fig. 51). Once the rat was stable under
standardized conditions the bilateral phrenic nerve recordings and blood pressure were
recorded on the Spike 2® software. Blood pressure was monitored and intravenous fluids
(Lactated Ringers) were provided as needed.
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Figure 51: Example neurograms identifying the apneic and recruitment thresholds.
The top trace displays a neurogram of the right phrenic nerve demonstrating the bursting
pattern used to identify the apneic threshold. When the level of oxygen is increased the
descending signal from the rVRG is inhibited resulting in an absence of phrenic nerve
activity. An absence of signal for a minimum of 7 seconds is used to identify apnea, above
is a 13 second pause. Once apnea is identified, the end tidal CO2 level is set 3-5mmHG
higher by slowly decreasing the oxygen to the ventilator. The bottom trace displays a
neurogram after the apneic threshold had been identified and the end tidal CO2 levels were
adjusted. The stimuli to breath is stable and consistent as demonstrated by the consistent
bursting pattern displayed on the neurogram.

The rats were tested for presence or absence of recovered phrenic nerve activity
followed by quantification of the neurograms that demonstrate bilateral phrenic nerve
activity (see statistical analysis below).
Tissue preparation to visualize WGA
Three days after intradiaphragmatic injection of WGA-HRP-AuNP-proTHP, rats
were anesthetized with a mixture of ketamine (70mg/kg, ip) and xylazine (7mg/kg, ip). The
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rats were transcardially perfused with 150 mL of heparinized saline followed by 350 mL of
4% Formaldehyde in 0.1M phosphate-buffered saline (pH 7.4). The spinal cord (C3-C6) and
medulla were removed and an insect pin was inserted along the longitudinal axis of both on
the right to differentiate the left from the right side. The medullary and spinal tissues were
post-fixed in the perfusate overnight and cryoprotected 2-3 days in 30% sucrose in 0.1M
PBS until the medulla sinks. Transverse sections (50microns) through the medulla and
spinal cord were cut with a cryostat and collected in 0.1M PBS.
Tissue sections were washed in immunobuffer for 10 minutes (x3) followed by
incubation in 10% Normal Horse Serum (NHS) blocking solution for 30 minutes. Sections
were incubated in a primary antibody, anti-WGA made in goat (Vector labs, batch 2024)
with a 1:200 concentrations in 10% NHS. Sections remained in the primary antibody for 72
hours. Sections were then washed in Tris-PBS for 10 minutes (x3). Sections where then
incubated in a secondary antibody, Biotin-Donkey anti-goat (Jackson ImmunoResearch,
batch 113055) with a 1:400 concentrations in 1%NHS. Sections remained in the secondary
antibody for 24 hours. The sections were washed in Tris-PBS for 10 minutes (x3). Sections
were then incubated in Cy 3 Streptavidin (Jackson ImmunoResearch) diluted in
immunobuffer with a 1:1000 concentration for 4 hours. After the addition of Cy 3 Streptavidin
the sections were covered in foil to limit exposure to lights. Sections were washed in TrisPBS for 10 minutes (x3) and mounted on slides. Buffered glycerol (pH 8.6) was placed on
to the sections and covered slipped (Strack and Loewy, 1990). Tissue sections were
examined on a Zeiss Axioimager.M2 fluorescent microscope using the red filter. Images
were captured using the Zen 2 pro Blue edition program.
Statistical analysis of EMG and neurogram recordings
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All statistical test of EMG data was performed in SigmaPlot 13.0. Qualitative analysis
of EMG data was performed as described by Minic et al., 2016. As stated by Minic et al.,
2016 only the incidence of recovery was quantitated not the amount of recovery. Treatment
groups were divided into a Yes or No category based on recovery (return of function to the
left hemidiaphragm) or the absence of activity respectfully. Recovery was classified as a
return of activity in any two sections of the left hemidiaphragm (anterior, lateral, posterior).
For comparison between two groups, the Fisher exact test was performed to determine if
the ratio of Yes/No for each group was statistically different. When more than two groups
were being compared, the Chi-square test with alpha = 0.010 was performed to determine
if there was significance within the group as a whole. In addition to the Chi-square, each
group was compared pairwise with the Fisher exact test to identify significance between
each pair of groups. All graphs for EMG data were made in Excel.
Data was obtained from the bilateral phrenic nerve recording procedure once the
apneic threshold was established and the rat was stabilized near the recruitment threshold.
Once stabilized 10 consecutive breaths were sampled (Fig. 52). The sampled data from
Spike was exported to Excel. The baselines (noise) for the 10 breaths of the right and left
neurograms, determined in Spike, were subtracted from the right a left set of data points
respectfully in Excel. The area under the curves (AUC) from the right and left rectified and
integrated waveforms (INT) were calculated. The percent recovery of the left INT compared
to the right INT (right=100%) was calculated for each breath, then the average % INT was
calculated. Then the maximum amplitude was identified for each of the 10 breaths. The
percent maximum amplitude (MAX) of the left compared to the right (right=100%) was
calculated for each breath, then the average % MAX was calculated. The average % INT
and the average % MAX for each group was averaged. The average percent recovery for
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INT and MAX from each group was then compared and subjected to statistical examination
using SigmaPlot 13.0. All groups underwent One-way ANOVA (alpha=0.050) followed by
Holm-Sidak pairwise comparison to determine the effect of the injected solution on the
percent recovery and percent max recovery. All graphs for neurogram data were made in
SigmaPlot 13.0.
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Figure 52: Phrenic nerve tracing. The neurogram displayed here was recorded on day 7
post injection. L Int, integrated left waveform; LPN, left phrenic nerve signal in volts; R Int,
integrated right waveform; RPN, right phrenic nerve signal in volts. The top trace is a sample
of the neurogram that spans over 130 seconds. The bottom trace is a sample of 10 breaths
from the boxed area in the top trace. To calculate LPN recovery, background was
subtracted from the integrated waveforms. Then the area under the curve was calculated
for the R and LPN. Left was expressed as a percentage of right. In addition, the maximum
amplitude for each burst was calculated from the R and L integrated waveforms and the left
was expressed as a percentage of right.
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APPENDIX
Nanoconjugate Patent Information
The work presented herein has been submitted for patenting: “Transporter ProteinCoupled Nanodevices for Targeted Drug Delivery”, First Named Inventor/Applicant Name:
Harry Goshgarian (co-inventors: Guangzhao Mao, Yanhua Zhang). Original Assignee:
Wayne State University. Application number: 14/534,994, Application type: Utility/Design
using an application data sheet (37 CFR 1.76), Date Filed: November 6, 2014. Publication
number: US20150125926 A1.
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ABSTRACT
AN ANALYSIS OF PLASTICITY IN THE RAT RESPIRATORY SYSTEM FOLLOWING
CERVICAL SPINAL CORD INJURY AND THE APPLICATION OF
NANOTECHNOLOGY TO INDUCE OR ENHANCE RECOVERY OF DIAPHRAGM
by
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Degree: Doctor of Philosophy
Second cervical segment spinal cord hemisection (C2Hx) results in ipsilateral
hemidiaphragm paralysis. However, the intact latent crossed phrenic pathway can restore
function spontaneously over time or immediately following drug administration.
WGA bound fluorochromes were administered to identify nuclei associated with
diaphragm function in both the acute and chronic C2Hx models. WGA is unique in that it
undergoes receptor mediated endocytosis and is transsynaptically transported across
select physiologically active synapses. Comparison of labeling in the acutely injured to the
chronically injured rat provided an anatomical map of spinal and supraspinal injury induced
synaptic plasticity. The plasticity occurs over time in the chronic C2Hx model in an effort to
adapt to the loss of hemidiaphragm function.
Utilizing the selectivity of WGA, a nanoconjugate was developed to target drug
delivery to nuclei involved in diaphragm function post C2Hx in an effort to restore lost
function. Theophylline was selected due to its established history as a respiratory stimulant.
Theophylline was attached to gold nanoparticles by a transient bond designed to degrade
intracellularly. The gold nanoparticles were then permanently attached to WGA-HRP.
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Following intradiaphragmatic injection, the WGA portion was identified in the ipsilateral
phrenic nuclei and bilaterally in the rVRGs. The location of WGA should reflect the location
of the AuNP since the peptide bond between them is permanent.
The effectiveness of the nanoconjugate was verified with EMG analysis of the
diaphragm and recordings from the phrenic nerves. All doses administered in the acute
C2Hx model resulted in resorted hemidiaphragm and phrenic nerve activity. A dose of
0.14mg/kg had a significantly higher percent recovery on day 3, whereas 0.03mg/kg was
significantly higher on day 14. The change in most effective dose over time is likely due to
the availability or concentration of the drug and location of drug release. Administration of
the nanoconjugate was also characterized in the chronically C2Hx model. The dose
0.06mg/kg resulted in significant recovery when injected 12 weeks post-C2Hx. This data
suggests that WGA bound nanoconjugates are able to undergo endocytosis. In addition,
the theophylline bound nanoconjugate is capable of restoring hemidiaphragm and phrenic
nerve activity.
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